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Abstract
Probing the Limits of Singular Gene Expression Through the Activity
of High Representation Odorant Receptor Transgenes
by
EUGENE LEMPERT
Advisor: Dr. Paul G. Feinstein

Singular gene expression is a common phenomenon in biology, making its appearance in
immunoglobulin selection, protocadherin expression, X chromosome-inactivation, random monoallelic
expression, and olfactory receptor choice. Singularity involves an activation and a feedback step. The
mechanisms of singular gene choice have some capacity to integrate additional member genes while still
maintaining singularity, but will activate an additional member if an earlier choice was incapable of
triggering the feedback step. Odorant Receptor (OR) genes are substantially divergent from each other in
terms of coding sequence, promoter structure, and genomic locus, all of which plays a role in how many
Olfactory Sensory Neurons (OSNs) express a specific OR gene in singularity. The number of OSNs that
express a specific OR gene, referred to as “representation” in this thesis, was previously enhanced
through the five prime addition of a multimerized homeodomain enhancer sequence derived from OR
enhancers. These "High Representation" (HR) OR transgenes maintain the properties of singularity, but
the use of the exogenous tTA/TetO expression system to generate singular OR expression in OSNs
suggests that singularity is not unique to OR promoters and enhancers. The intersection of HR and
tTA/TetO transgenes reveals a competitive hierarchy in the OSN nucleus, in which the order of activation
dictates the hierarchal relationship between HR transgenes and TetO transgenes. The capacity for HR
transgenes to limit TetO activity even when replacing the OR coding sequence of either transgene with a
marker coding sequence suggests a more generalized mechanism to explain how OSNs and other
systems generate singularity.
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Preface
“We are a way for the cosmos to know itself.”
― Carl Sagan, Cosmos

We as humans are a byproduct of the basic, derivative, and emergent processes that we seek to
understand. As such, we are restricted in our understanding due to how our faculties developed through
these processes. For the last four billion years, genetic mutation was the unwitting driver of differential
survival and propagation. The fuzzy beginnings of life required translation of environmental stimuli into
profitable responses. Modifications that were advantageous or tolerable, as deemed by the environment,
spread into future generations. Functional success in sensory development, through allowing organisms
to exploit ever-present stimuli, is still nothing more than a limited translation of more fundamental
properties. Vision responds to a narrow band of the electromagnetic spectrum; hearing is activated by
waves of molecular collisions; the various tactile senses are triggered by physical molecular interactions;
static and dynamic equilibrium use gravity and inertia; and the chemosensory systems exploit particlereceptor affinities. Our minds have evolved alongside these systems to convert sensations into relevant
interpretations, those promoting survival and propagation. The development of modern man did not
remove us from those basic drives and their associated mental circuitry; a similar electrochemical logic
applies to all senses, and evolution merely integrated the new sense of “self” with the existing sensory
systems.
Categorization of sensory signals as positive or negative, safe or dangerous, similar or different
is suggestively beneficial in the survival of the individual and the species. We categorize everything:
locations, organisms, people, beliefs, ideas, and so forth. While the propensity to sort and segregate has
allowed humanity to prosper, this inclination drives our thoughts and actions in seemingly neutral and
negative ways as well. Our minds successfully evolved to interpret the world around us within a sensory
range that’s relevant to our survival: medium-sized objects, moving at medium speeds, emitting a narrow
range of electromagnetic radiation, and releasing some subset of chemicals. Outside those limits, our
vii

evolutionarily conserved intuition requires analogies to bring the world of the tiny and the huge back to
our scale of understanding. This act of grouping foreign concepts into familiar categories allows us to
rapidly integrate the new information, but this unintentionally makes it difficult to escape from our range of
thinking.
A coin flip appears to generate a random result of either heads or tails, but in reality there are
numerous factors that contribute and generate those conclusions: the weight of the coin, the angle of the
flip, the imparted angular momentum, air resistance, properties of the landing surface and its interaction
with the falling coin, the breathing of the participants, the location on earth, the season, the position of the
moon, and so on. Though the contribution of all these factors is possibly beyond our ability to calculate,
the coin flip will inevitably resolve into a heads, tails, or far less commonly on the edge. This resolution of
complicated interactions is common when scaling up from tiny worlds, generating entire fields of research,
such as thermodynamics or fluid dynamics. Our inability to adequately account for all molecular
movements and interactions places us in a position to consider the end-state of their activity, the
resolution or the average. Though conceptually abstract, the ability to estimate probabilities and
outcomes without needing to consider every factor might be a mental faculty developed during our
evolutionary history. In a cellular setting, we use these readouts to characterize the function of particular
components, but at this scale the exact movements and interactions of said components are more
nuanced than an averaging readout would suggest.
I have an obsession with presenting my work in a certain order to the point of crippling my output,
and the above was exactly that. My intention with the last few paragraphs is to provide the reader with
some insight into my thoughts. Though the ideas are oversimplified, incomplete, speculative, and possibly
incorrect, they highlight my perspective on humans and humanity, and the research we perform.
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Chapter 1: Introduction
The Olfactory System, the Olfactory Sensory Neuron, and the Odorant Receptor
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1.1 Olfaction Overview
Olfaction allows organisms to interpret environmental molecules for the purpose of survival and
reproduction. Analogous to the other senses, molecules that can produce a signal will vary significantly
between species and more subtly between members of the same species1,2. The signal is generated
upon interaction between odor molecules and protein receptors, each molecule interacting with a variety
of receptors, and each receptor binding multiple different molecules 3. Odorant Receptors (ORs) are
expressed in the sensory neurons of the nasal epithelium lining the boney labyrinth and nasal septum of
the nasal cavity. From the hundreds or thousands of OR genes, each Olfactory Sensory Neuron (OSN)
expresses only one OR at high levels, limited further to just one allele of the two4–7. This property, termed
“singularity”, is considered fairly robust for the millions of mature OSNs within the sensory epithelium.

1.2 Structure of the Olfactory System
The olfactory epithelium is a specialized pseudostratified epithelium with OSNs accounting for the
bulk of the tissue with regenerative precursor cells located at the basal end and supportive Sustentacular
cells securing the apical surface8 (Fig. 1). Microvillous cells represent a fourth population, though their
function is less well understood9. The olfactory epithelium forms an outer layer covering part of the nasal
cavity, which includes the turbinates or conchae- boney projections that emerge from the cavity walls
(Fig. 2). OSN dendrites extend passed the Sustentacular cell layer, ending in a dendritic knob that
projects numerous sensory cilia across the turbinate surface10 (Fig. 3). OSN axons pass through the
basal cell layer and enter the underlying connective tissue to converge with other OSN axons into
bundles that travel towards the Olfactory Bulbs (Fig. 4, Fig. 12B). Once passed the cribiform plate, the
axon nerves spread out across the Olfactory Bulb surface with individual axons separating from the
bundles and converging into synaptic structures called glomeruli, deep to the outer layers 11 (Fig. 5). From
the glomeruli, OSN axons communicate their odor-induced activity to mitral/tufted neurons, which take the
signal further into the brain for processing12,13.
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Fig. 1. Cellular composition of the Main Olfactory Epithelium. A. TO-PRO-3 stains nucleotides and marks all cells in the
epithelium. B. Anti-Golf antibody marks OSNs and cilia. C. Merge with TO-PRO-3 in Red and Anti-Golf in Green, revealing nuclei
not surrounded by Golf. Panel D. An interpretation of Panel C with the Yellow circles defining OSNs, the Red circles demarcating
Basal Stem Cells, Immature OSNs and intermediate precursor cells, and Brown circles defining supportive Sustentacular Cells
and perhaps Microvillous cells.

Fig. 2. The Olfactory Turbinates of the Nasal Cavity. FASEB 2018 BioArt Winner. The Olfactory Epithelium, visible as a green,
blue, and red layer, covers much of the nasal cavity surface including the turbinates that project into the nasal cavity and the
septum that separates the nasal cavity into two isolated compartments. Image was produced by Lu Yang, David Ornitz and SungHo Huh. Image source: https://faseb.org/Publications-and-Resources/BioArt/Past-Winners/2018-BioArt-Winners.aspx
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Fig. 3. The Structure of an Olfactory Sensory Neuron.
The OSN cell body lies within the epithelium. The OSN
dendrite projects towards the apical layer of mucus and
ends in a dendritic knob that contains numerous cilia that
spread out perpendicular to the mucus layer. Odor
detection occurs in the OR-rich cilia. The OSN axon
projects towards the basal surface, penetrates the lamina
propria and travels through the underlying connective
tissue towards the brain. Image adapted from Mori &
Yoshihara (1995)11.

Fig. 4. The journey of an OSN axon. OSNs lining the
Olfactory Epithelium project their axons into bundles that pass
through the Cribiform Plate and travel across the surface of the
Olfactory Bulbs prior to projecting into glomeruli. OSNs, axons,
and glomeruli are marked by the 5V transgene in green and
Anti-Golf antibody in red.

Fig. 5. Layers of the Main Olfactory Bulbs. OSN
axons travel across the bulb surface through the
external and internal nerve layers. The glomerular
layer is composed of OSN axons, mitral/tufted
neuron dendrites, and periglomerular cells. The
external plexiform layer contains the dendritic
projections from mitral/tufted neurons, whose cell
bodies are located in the mitral cell layer. The
granule cell layer forms the boundary between
mitral/tufted neuron cells bodies and axons that
project deeper into the brain. Layers demarcated by
M71-Cre/ROSA-MTMG in green, P-LacZ via Antiβgal+AF647 antibodies in red, and ROSA-MTMG in
greyscale.
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1.3 Development of the Olfactory System
The olfactory epithelium begins development as a morphologically indistinct subpopulation of the
sensory placode on the early embryo, though the final structure is partially derived from neural crest
cells8,14,15. Early differential patterning establishes the olfactory placodes, which become nasal disks and
later invaginate into the presumptive head to form the nasal cavity15,16. Turbinate growth requires interplay
between the epithelial cells and underlying mesenchyme and cartilage17,18 (Fig. 6A), analogous to the
development of other branching structures such as the lung19. The variability in turbinate complexity
between species can be partially accounted for by differences in this developmental interplay 20 (Fig. 6B).

Fig. 6. Development of the Olfactory Turbinates. A. Turbinate growth coincides with the expansion of olfactory
epithelium. S:septum, n & c: turbinates, OE: olfactory epithelium, E:embryonic day. Image source: Yang & Ornitz (2018) 18.
B. Different examples of turbinate structure in mammals and birds. Image source: Owerkowicz, et al. (2017)20.

The early epithelium is an unstructured population of precursor, neuronal, and non-neuronal cells,
as opposed to the layered basal-to-apical cell type distribution of the post-natal nasal epithelium 21,22 (Fig.
7A). Mature OSNs in adult mice develop from a mitotic precursor biased towards a neuronal fate, passing
through a post-mitotic immature stage prior to obtaining the morphology and mRNA expression pattern of
a terminal OSN23–25 (Fig. 7B). Presumptive pioneer cells and neurons within the immature epithelium
make contact with the telencephalon, which correlates with the emergence of the olfactory bulbs 14,15,26,27.
The presence of an active basal stem cell population in the olfactory epithelium means the olfactory
system is always developing. The peripheral olfactory system is exposed to the external environment and
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the residing cells die frequently. OSNs in an adult animal survive approximately 4-8 weeks prior to being
regenerated by the basal stem cells, though some OSNs survive longer 28–30.

Fig. 7. The development of the olfactory epithelium and its resident cells. A. The structure and composition of the
olfactory epithelium changes during embryogenesis. AL: apical layer, IL: intermediate layer, BL: basal layer, imOSN:
immature OSN, IP: intermediate progenitor cells, oNSC: olfactory neural stem cell, SUS: Sustentacular cell, mOSN: mature
OSN, MC: microvillous cell, BG: bowman’s gland, GBC: globose basal cell, HBC: horizontal basal cell, OEC: olfactory
ensheathing cell. Image Source: Sokpor, et al (2018)22. B. The developmental fate map of olfactory stem cells. The mature
OSN requires a precursor cell to pass through numerous cell states prior to being committed to an OSN fate. Image source:
Fletcher, et al (2017)23.

1.4 OR Gene Family
Odors are detected by Odorant Receptors (ORs) expressed in OSNs. In mice, there are
approximately one thousand OR genes and several hundred pseudogenes; they are distributed
throughout most chromosomes as either individual units or as part of clusters of up to and over one
hundred members3,31–35 (Fig. 8). The human OR gene repertoire contains approximately 300 functional
genes and 700 pseudogenes36–39. OR gene structure is fairly simple with a single coding exon and a few
non-coding exons covering approximately 8000 base pairs 40. OR genes are part of Rhodopsin-like family
of evolutionarily ancient GPCRs and have reached their current state via gene duplication, deletion,
transposition, expansion and mutation38,40,41.
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Fig. 8. Odorant Receptor genes
are distributed throughout the
mouse genome. OR loci are
indicated in red, except for those
with no intact OR genes, which are
shown in green. The position of
each locus (blue) is shown on the
left in Mb from the centromere
(top). The number of intact OR
genes and OR pseudogenes and
the number of subfamilies encoded
are indicated on the right for each
locus and above for each
chromosome [intact genes
(subfamilies)/pseudogenes]. Image
and figure caption from Godfrey, et
al (2004)32.

Endogenous ORs are part of the 25% of all genes that are not transcriptionally primed in
embryonic stem cell lines42. In adult animals, OR genes are selectively transcribed outside OSNs 43–47,
though OR functionality in these regions is debatable48. Correlatively, OR clusters carry more silencing
marks in comparison to neighboring genetic regions 49. In addition, the relative levels of silencing marks on
OR genes is further intensified in OSNs with the exception of the expressed OR gene. OR genes are
notoriously difficult to study in heterologous cells lines and require co-expression with trafficking proteins
or the use of specialized cell lines to force some of the OR protein to make it to the cell surface 50–53.

1.5 OR Protein Signaling
Odorant Receptors are 7-transmembrane, G-Protein-Coupled Receptors (GPCR) composed of
approximately 309 amino acid residues each. The massive OR gene family produces OR proteins with
amino acid sequence similarity ranging from approximately 20% to at least 96% between any two OR
proteins54 (Fig. 9A). This broad range of protein structure allows the olfactory system to become active in
response to potentially trillions of molecules55, though the capacity for odor discrimination is likely
significantly lower.
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Fig. 9. Odorant Receptors are 7-transmembrane, G-Protein-Coupled Receptors. A. Simplified graphic for the proposed
structure of ORs showing the range of amino acid residue conservation at each position. Image Source: Niimura (2012) 3. B.
Odor-mediated signal cascade via the activity of a G-Protein Complex, Adenylyl Cyclase III (ACIII), cAMP, and downstream ion
channels. Image Source: Ha and Smith (2009)58.

As 7-Transmembrane receptors, ORs form an extracellular pocket to interact with environmental
molecules and an intracellular pocket to generate a signal cascade11. As GPCRs, ORs mediate the signal
via stable association with a G-Protein Complex56,57 (Fig. 9B). Upon ligand interaction, the alpha subunit
of the complex becomes functional, activating Adenylyl Cyclase III, which will convert ATP into the
secondary messenger cAMP. The elevated levels of cAMP will open up the Cyclic Nucleotide-Gated
Channels, allowing sodium and calcium into the cell, with calcium opening up Calcium-Gated Chloride
Channels, together leading to local membrane depolarization 58,59. With enough receptors activated, the
depolarization wave can reach threshold levels to achieve an action potential, which will travel down the
axons and towards the glomeruli in the olfactory bulbs.

1.6 Singular OR expression in OSNs
Each mature OSN will express one allele of one OR gene from the entire OR gene repertoire 4–
6,60–75.

The immature OSN can present multiple OR mRNA species at the same time, but the levels are

significantly lower compared to mature OSNs6,72. In these single-cell analyses, the highly expressed OR
is often associated with low level expression of a second OR locus. Thus, the high-level expression of a
single OR allele is the metric for Singular OR expression and the defining point for the cellular identity and
properties of the host OSN described in the following sections76.

1.7 Singular OR expression and Homogeneous Glomeruli
Glomeruli are formed from OSNs axons and Mitral/Tufted cells dendrites 37. Each OSN expresses
only one OR allele and will only converge into glomeruli with axons of OSNs that express the same OR
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protein at similar expression levels76 (Fig. 10). Glomeruli are not always homogeneous and stray axons
will find themselves outside the expected glomerulus or even appear non-convergent, but the connection
between the expressed OR and axon convergence is undeniable 77–85. The mechanism by which the OR
mediates this convergence property is still contested in the literature.
Each OR is associated with OSNs projections that coalesce at two fairly consistent locations on
each olfactory bulb37,75,86. The sites are mirrored across a line of symmetry that divides each bulb into a
rough dorsomedial and ventrolateral region87. Generally, each half-bulb will contain one glomerulus for
each OR, but that number can vary depending on the OR, the age, genetic background, and experimental
treatments8,78,88.

Fig. 10. Olfactory Sensory Neurons that express the same
OR in singularity will converge their axons into
homogeneous glomeruli. Each glomerulus of the Main
Olfactory Bulb is associated with a single mitral/tufted neuron.
The connection between the epithelium and bulbs is further
dissected in Chapters 1.8 and 1.9. Image Source: Mombaerts
(2006)54.

1.8 Zones of expression and domains of projection
Each specific OR is associated with sporadic expression within a visually discontinuous subset of
the olfactory epithelium called a “zone”89. Discontinuous zones are likely a consequence of the
developing turbinates and expanding epithelium83. Though neither perspective is entirely adequate to
demonstrate the complexity of the zones, these restricted subsets can be visualized on the turbinate
surface or through coronal sections90–95 (Fig. 11A,B). This zonal pattern can be recovered by the basal
stem cells after inducing lesions in the olfactory epithelium 96. Additionally, there appears to be a link
between the region of OR expression within the epithelium and the region of the associated glomeruli in
the olfactory bulbs. A less defined split of the epithelial zones into a dorsal and ventral collection is
associated with projecting towards the dorsal and ventral domains of the olfactory bulbs, respectively95,97
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(Fig. 11C). Dorsal OSNs are defined by NQO1 expression and Ventral OSNs are marked by OCAM
expression98; NQO1 is found on the Dorsal olfactory bulb surface and OCAM is localized to the Ventral
olfactory bulb surface99. Though not as robust as zonal pattern reproduction, bulk OSN regeneration will
roughly reproduce sites of glomerular projection, albeit with certain experimental conditions producing
non-convergent glomeruli and some level of heterogeneity8,78,100.

Fig. 11. Individual Odorant Receptors are expressed in restricted regions of the olfactory epithelium. A. Zones I-IV of
the turbinate surface, including the Patch Zone (P). Image Source: Fuss & Ray (2009)94. B Five overlapping zones of
expression in the olfactory epithelium from the medial to lateral position. These zones (1-4b) of OR expression are also linked
to the position of the associated glomeruli. Image Source: Miyamichi, et al (2005) 90. C. The most dorsal zone of OR
expression is associated with a dorsal glomerular position, and likewise for the ventral zone in the epithelium and olfactory
bulbs. Image Source: DeMaria & Ngai (2010)97.

1.9 OR Class Properties
Evolutionarily, mouse OR genes can be divided into a Class I or Class II designation3.
These two classes represent the expansion of ancestral OR genes in terrestrial animals, each class with
its own properties that distinguish them from each other. Class I OR genes have approximately 100
member genes located within a single cluster; Class II OR genes are found throughout the genome in
clusters of various size. Class I ORs are almost exclusively expressed in the dorsal zone of the epithelium
and project their axons into a segregated dorsal domain on the olfactory bulbs 87,99,101,102 (Fig. 12A). Class
II ORs follow the dorsal/ventral segregation pattern and form a domain of dorsal glomeruli around the
Class I domain. A third “class” of GPCRs in the nasal cavity is the Trace Amine-Associated Receptors
(TAARs)102–104. These receptor genes are within a single cluster, are expressed in singularity in the dorsal
zone OSNs, and project to their own dorsal domain on the olfactory bulbs102 (Fig. 12B). This class-linked
glomerular compartmentalization is notable due to the intermingling of the associated OSNs within the
dorsal epithelium and is discussed further in Section 1.17.
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Fig. 12. Specific classes of olfactory receptors are associated with independent glomerular domains. A. Within the
dorsal zone of the epithelium, Class I and Class II ORs are expressed, but will project to two independent domains on the dorsal
bulb surface. The Class II ORs expressed in the ventral zone of the epithelium project to a ventral domain on the olfactory bulb.
Image Source: http://www.bs.s.u-tokyo.ac.jp/integr-life/english/findings/research071107.html B. Using a quirk of OSNs to
visualize class expression, three different receptor classes project to independent glomerular domains. Class I-Yellow. Class IIRed. TAAR class- Blue. Modified from Image Source: Pacifico, et al. (2012)102. The dorsal perspective, orientation, and related
terminology of these paired/mirrored Olfactory Bulbs is used throughout the thesis: Anterior (A)- towards Olfactory Epithelium;
Posterior (P)- towards the brain; Medial (M)/Lateral (L)- towards or away from the midline, respectively. The Ventral portion of
the bulbs is not in view from this perspective.

As opposed to the presumed developmental clarity of the single Class I OR and TAAR gene
clusters, the evolutionary history of Class II ORs is difficult to trace. Neighboring Class II OR genes within
clusters need not necessarily be closely related in terms of sequence homology, epithelial region of
expression, odor-binding profile, OSN representation, or localization of the axon fibers and glomeruli 3,89.

1.10 Additional Olfactory Systems in the Nasal Cavity
The OSNs of the Main Olfactory Epithelium that express Class I, Class II, and TAAR genes do
not represent all volatile-molecule-based sensory systems in the nasal cavity105–108 (Fig. 13A). Many of
these systems can be identified by their shared expression of the Olfactory Marker Protein gene (OMP)
(Fig. 13B). The Septal Organ is an isolated island of olfactory epithelium that contains OSNs that are
structurally and functionally identical to OSNs in the Main Olfactory Epithelium, but express a biased
subset of OR genes109,110. Necklace Sensory Neurons are located within recesses of the Main Olfactory
Epithelium, use guanylyl cyclase-D (GC-D) as opposed to adenylyl cyclase III for signaling, co-express
several members of the non-GPCR MS4A receptor family instead of ORs, and project their axons into
interconnected “necklace” glomeruli111,112. Anatomically isolated from the nasal cavity, the Grueneberg
Ganglion neurons express guanylyl cyclase-A and cyclase-G, and converge axons into “necklace-like”
glomeruli that are similar to, but mutually exclusive from the glomeruli of Necklace Sensory Neurons 113,114.
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Fig. 13. Numerous odorant-detecting subsystems are present in and around the nasal cavity. GG: Grueneberg
Ganglion. GCD: Guanylate Cyclase-D Neurons. MOE: Main Olfactory Epithelium. VNO: Vomeronasal Organ. SOM/SO:
Septal Organ. MOB: Main Olfactory Bulb. AOB: Accessory Olfactory Bulb. NG: Necklace Glomeruli. A. Image Source:
Brennan & Zufall (2006)107. B. OMP driving LacZ expression, visualized via X-gal. Image Source: Munger, et al. (2009)108.

Fig. 14. The Vomeronasal Organ, sensory neurons, receptors, glomeruli, and signal integration properties vary from
those associated with OSNs in the olfactory epithelium and olfactory bulb. Sharing a distant evolutionary history, these
two systems nonetheless have chemoreceptor-presenting neurons that directly connect the outside environment and the central
nervous system. The two systems are likely governed by the same core principles. See Section 1.2 and 1.10 to compare their
properties. Image Source: Dulac & Wagner (2006)122.

The Vomeronasal Organ (VNO) is located at the bottom of the nasal septum, visualized as a twopart crescent-shaped structure mirrored across the septal wall91,105,115–117. The sensory epithelium is
divided into an apical and basal layer, each expressing a distinct category of Vomeronasal Receptors
(VRs); V1Rs in the apical neurons and V2Rs in the basal neurons115. In addition, mutually exclusive
Formyl peptide receptor expression marks some of the neurons in the VNO 118,119. Neurons in the VNO
project into an Accessory Olfactory Bulb, located at the posterior-dorsal end of the Main Olfactory Bulbs
(Fig. 14). Apical neurons project into rostal glomeruli and basal neurons project into caudal glomeruli; this
relationship is reinforced by OCAM-signal in the apical layer and rostral glomeruli and not in the basal
layer and caudal glomeruli120. Though homogeneous glomeruli formation is a common theme, each VR is
associated with several small glomeruli. Additionally, each singularly expressed family A, B, or D V2R is
coordinately coexpressed with one family C V2R121,122; unlike OR-associated glomeruli, numerous VR
glomeruli can integrate their activity into a single mitral/tufted neuron91,121,123,124.
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1.11 ORs are not equally represented in the OSN population
In this thesis, the number of OSNs that express a specific OR is called “representation”, a
concept distinct from the spatial property normally associated with neuroscience. The representation for
each OR is not equivalent125,126. OR representation ranges from under one thousand host OSNs to over
40,000 cells. Neighboring OR genes within the same cluster can present such variable representation, as
in the case of the MOR28 (Olfr1507) gene represented in an estimated 10% of all OSNs found within its
specific zone of the epithelium, compared to the more modest representation of neighboring MOR10 and
MOR83 genes127. Similarly, M71 (Olfr151) and M72 (Olfr160) are within 30kb of each other and generate
ORs that have 96% homology, but their representation differs 2-3 fold76,128.

1.12 OR transgenes can reproduce endogenous OR gene zones of
representation
The promoters of ORs as grouped by class or epithelial range of expression have different protein
binding site composition94 (Fig. 15). Though transgenes tend to suffer from position-effect-variegation, a
transgene composed of an OR promoter and OR coding sequence will often, but not always, reproduce
its endogenous representation pattern4,93,129–131. Manipulating an endogenous promoter will change this
zone of representation, highlighting the relevance of the promoter sequence131. The level of OSN
representation can vary between individual OR transgene lines likely due to their site of integration, but
the locus can also influence the zone of expression93,128,132. Using a non-OR promoter to drive OR protein
will either fail to properly express, or generates ubiquitous co-expression with an endogenous OR
gene79,133,134. Though the locus of integration has some influence on expression properties, an OR
transgene contains all the elements sufficient to reproduce not just OSN-specific expression, but also the
restricted zonal characteristics of the original endogenous OR gene.
Fig. 15. Odorant Receptors
expressed in different zones
have different promoter
compositions. The variability in
promoter structure drives
restricted zones of expression,
but the common promoter
elements suggest common
mechanisms of activation. Image
Source: Fuss and Ray (2009)94.
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1.13 An OR promoter is adequate to reproduce an OR zone of representation
The promoter of an OR gene linked to a non-OR coding sequence reproduces the zone of
expression associated with that OR gene, thus the OR coding sequence is dispensable for this
property70,79,110,128,135,136. As suggested in Figure 15, the promoter elements of OR genes are not unique
from each other, yet the variable element spacing, specific nucleotide differences that exist between
different OR promoters, and gene locus restrict expression to some subset of OSNs. Thus the information
that defines the OSN subset biased towards activating a specific OR is partly located within its promoter.
To further exemplify the value of the promoter for any particular OR, within the Class I cluster are
two OR genes that have Class I OR coding sequences, but contain promoters more closely resembling
Class II OR promoters137. These two ORs genes are expressed in OSNs that intermingle with the ventral
Class II OR-associated OSNs99,101.

1.14 “Null OR” genes result in the expression of a second OR gene
OSNs that express the same OR converge into a small number of homogeneous glomeruli. The
deletion of an OR coding sequence will reproduce the zone of expression, but results in axons that do not
converge together and instead spread out across some region of the bulb surface with a few fibers
entering several glomeruli70,99,110,128,135,136,138 (Fig. 16). Rather than the OSN presenting a “null OR”
identity, the literature is in agreement that the OSN expressing the “null OR” is also expressing another
OR locus from some subset of OR loci. Even though the co-expression of two OR loci- one with a null and
the other functional, seems to break the rule of singularity, only one functional OR gene is activated.

Fig. 16. Deletion of OR coding
sequences marks OSN axons
that project into numerous
glomeruli. Visualized with an
EGFP tag via an IRES sequence,
(A) the endogenous and transgenic
MOR28 genes produce glomeruli,
(B) while the deletion MOR28 lines
fail to mark converging glomerular
structures. (C,D) With an antibody
against EGFP in red and nuclear
DAPI staining in blue, it is evident
that the deletion fibers fail to
converge together. Image Source:
Serizawa, et al (2003)70.
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Thus, the singular nature of the expressed OR protein provides an OR identity that converges the
axon into a glomerulus associated with that OR. With numerous OR identities associated with the marked
“null OR” OSNs, the axons will appear to fan out across the bulb. Hundreds of OR pseudogenes exist in
the mouse genome, which might be evolutionarily neutral because the OSN is capable of selecting
additional, functionally overlapping, OR loci for activation3.

1.15 Singularity and/or glomerular formation can be mediated by other GPCRs
The expression of a marker protein using an OR promoter does not generate singular OR locus
activity, while the expression of an OR protein via the same promoter will produce singularity and
homogeneous glomeruli. The broad range of OR homology suggests that the measure of a “functional
OR” required for OSN development need not be so strict. Certain GPCRs act like surrogate ORs and
achieve similar results to OR proteins, resulting in singularity and the formation of glomeruli 52,136,139,140;
these include DRD1A, B2AR and MC4R.
Modification of OR proteins can lead to novel identities and glomeruli76. A subset of modified ORs
neither generate homogeneous glomeruli, nor the “null OR” fanning out phenotype 136 associated with
deletions and possibly pseudogenes. These “neomorph” receptors lack signaling functionality or fail to
accumulate protein. Instead they reveal stunted axon outgrowth suggesting that signaling or protein levels
are important for OSN development, but are dispensable in initiating singularity and preventing the
activation of a second OR locus.

1.16 Enhancers modulate OR representation in cis
OR promoters contain Olf1/Ebf (O/E) and homeodomain binding sites94,132,137,141. LHX2 is a Lim
homeobox protein that binds homeodomain elements in OR promoters and is critical in OR expression
and OSN development131,142–147. O/E proteins are critical in B-cell and neuronal development, but are not
absolutely essential for OR and OSN functionality148. A DNA sequence containing several copies of these
two binding sites is found 70kb upstream of one of the highest represented OR genes- MOR28127. This
sequence called the H element is considered an enhancer of OR genes, though its impact is limited to
local cis genes70,127,147,149,150.
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Reducing the distance between the H element and MOR28 increases the representation of
MOR28 to approximately 80% of the epithelium; deletion of H ablates all expression from the MOR28
cluster, which include MOR10 and MOR83, with reduced or no impact on more distant loci127 (Fig. 17).
Presumptive OR Enhancers are found broadly distributed throughout the genome151,152. The P element
performs similarly to the H element, and importantly neither regulates mRNA levels, but rather increase
the representation of the associated OR genes150. A specific OR enhancer is associated with the Class I
OR gene cluster and required for Class I OR expression153,154. Multimerizing a homeodomain sequence
from the H element and introducing it upstream of an OR transgenic construct produces mouse founder
lines that almost always express the transgene and express it at high representation in the OSN
population147,155. As with other OR transgenes, these transgenes reproduce singular OR gene expression
and generate homogenous glomeruli that can converge with endogenous axons, but will form novel
glomeruli if a non-endogenous OR is introduced.

Fig. 17. Deleting the H element OR Enhancer
eliminates the representation of the linked OR
genes. In red, ISH against the mRNA of the MOR28
gene cluster reveal the connection between the H
element enhancer and the transcription of the linked OR
genes; deleting one H element decreases the number of
marked cells by 50%, supporting the cis role of the H
element. Image Source: Fuss, et al (2007)126.
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representation of the linked OR genes. In red, ISH
against the mRNA of the MOR28 gene cluster reveal the
connection between the H element enhancer and the
transcription of the linked OR genes; deleting one H
element decreases the number of marked cells by 50%,
supporting the cis role of the H element. Image Source:
Fuss, et al (2007)126.

transgene rarely expresses the Class I OR genes, rather co-expressing a Class II OR gene with a slight
bias towards the dorsal zone OR genes. Thus, the Olfactory Epithelium contains precursor cells subtypes
that are fated to express a receptor gene from a defined subset. The division of Class I and Class II OR
gene selection for an OSN is partly linked to the repression of the Class I Cluster OR Enhancer that is
otherwise dominant to Class II OR genes153,156.

1.18 The OR refines axonal properties
The promoter of an OR gene defines which OSNs will express the associated gene (Section
1.13). In the case of a “Null OR” gene, the OSN that expressed that “Null OR” promoter will also express
another OR gene promoter from some subset of all OR genes (Section 1.14). The axons will then project
into a subregion of a particular domain defined by the OSN Class (Class I, II, and TAARs). Small
modifications to an OR gene sequence and thus OR protein sequence will change the convergence
properties of the host OSN, resulting in shifts in glomerular position76. In the context of two near
homologous OR protein-coding genes, the resulting glomeruli can segregate completely, make contact,
intermingle axons, or become completely indistinguishable. The replacement of an OR coding sequence
with a different OR while maintaining the same promoter can produce shifts in the final glomerular
position within the glomerular domain associated with class of the promoter 61,79,99,136 (Fig. 18).

Fig. 18. Swapping only OR coding
sequences can impact the final
glomerular position, but not the
glomerular domain. (A1, B1, C1, and
D1) Wholemounts of the bulbs show the
relationship between the glomeruli
innervated by OR-IRES-tauGFP OSNs
(green), and the class II domain revealed
by X-gal/Fast Red Violet staining (red)
against P-LacZ-Tg. (A2, B2, C2, and D2)
Coronal OB sections labeled with intrinsic
GFP fluorescence (green), anti-βgal
antibodies against P-LacZ (red), and antiNQO1 antibodies to mark dorsal OSNs
(blue). (A3, B3, C3, and D3) High
magnification of anti-βgal signals in the
glomerular layer. (A4, B4, C4, and D4)
High magnification of all three markers
shows the location of individual glomeruli.
Overlay of red and blue is purple. Image
and modified caption Source: Bozza, et al
(2009)99.

17
Fig. 19. Epithelial proliferation during
prenatal development can link OR
zones of expression and their
glomerular position. At early stages of
development, precursor cells within the
DM region of the ventral zone undergo
high rates of cell proliferation, which

1.19 The OR locus defines onset of activation and correlates with OSN axon
properties
The Olfactory System in mice begins nasal cavity development around Embryonic day 9.5 (E9.5)
and take several days to resemble a proper cavity (Section 1.3). The early neurons of the immature
olfactory epithelium make contact with the telencephalon and penetrate that structure around E12. During
this period of embryogenesis, starting as early as E9, OR expression is already detectable 157. The OR
gene repertoire detectable by E11 is expressed from several chromosomes, but the frequency of OR
detection is biased towards only a few loci. MOR28 is one of the highest represented OR genes and its
H-linked cluster is one such readily detectable locus at E11.
Both dorsal and ventral ORs are detected at this early age, but the developing nasal cavity takes
time to fully develop the ventral zone of the epithelium 157,158. Though MOR28 is found in the more ventral
zone and thus its OSN representation does not increase until a later time point, MOR28 will still be one of
the first activated OR genes157. A proposed minimum number of OSNs is required to form and maintain a
glomerulus associated with a specific OR (Paul Feinstein, personal communication). Thus, one model
proposes that the more dorsally positioned OR zones reach the required OSN minimum first and
generate glomeruli in a corresponding position on the olfactory bulb158 (Fig. 19).

Fig. 19. Epithelial proliferation during prenatal development can link OR zones of expression and their glomerular
position. At early stages of development, precursor cells within the DM region of the ventral zone undergo high rates of cell
proliferation, which increases the number of immature OSNs. A wave of cell proliferation travels along the D–V axis of the OE
(top), from the DM- to VL-region. In accordance with the cell proliferation process, axon extension and glomerular formation
occur sequentially, from the dorsal to ventral regions of the OB. Image and Modified Caption Source: Eerdunfu, et al (2017)157.

Fig. 20. A simplified version of the Enhancer Hub model for Singularity. A model for essential and redundant functions of
an OR enhancer in cis and in trans respectively. Schematic representations of different states in the OSN nucleus (left) and
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corresponding transcriptional outputs (right). An OR gene (orange box) located proximal to an enhancer (orange circle) is
repressed by H3K9me3 (red flag). The cis-proximal enhancer may facilitate derepression of the OR chromatin landscape (green
flag) but is not sufficient for OR transcription. Multiple trans-interacting enhancers (colored circles) aggregate around the
transcribed cis-proximal OR (orange box). Image and Modified Caption Source: Markenscoff-Papdimitriou, et al (2014)151.Fig.
19. Epithelial proliferation during prenatal development can link OR zones of expression and their glomerular position.
At early stages of development, precursor cells within the DM region of the ventral zone undergo high rates of cell proliferation,
which increases the number of immature OSNs. A wave of cell proliferation travels along the D–V axis of the OE (top), from the
DM- to VL-region. In accordance with the cell proliferation process, axon extension and glomerular formation occur sequentially,

Some OR genes do not achieve adequate representation required for glomeruli convergence until
after birth and the associated axons meander across the bulb surface for several days81,83. The link
between singular OR expression and the formation of homogeneous glomeruli suggests that OR genes
without adequate representation will not form glomeruli and thus will not provide sensory information
about the odors that lead to their activation. As such, OR genes with high representation might be more
resistant to promoter or enhancer mutations in comparison to OR genes with borderline representation.
The functional overlap between receptors can contribute to the mutational degeneration of OR genes, but
also allows for the appearance of receptors with novel odor profiles.

1.20 Rationale for the presence of OSN subtypes
The spatial, evolutionary, developmental and functional similarities and differences evident in
olfactory subsystems suggest that more subtle states of segregation are possible. Class I ORs, Class II
ORs, and TAARs overlap in their expression within the olfactory epithelium and their OSNs project
towards the Main Olfactory Bulb, but each receptor category is located in different clusters in different loci
with host OSNs restricted to expressing only one class of receptor genes and projecting their axons to
only one domain of the olfactory bulb. The division between the ventral and dorsal Class II ORs is subtler
as neighboring OR genes in the same cluster can be expressed in spatially segregated OSNs 89. This
segregation might be subject to the OSN position on the turbinates as suggested by expression profile
conversions in the translocation of dorsal precursor cells into the ventral zone98. This segregation has the
potential to become as strict as the class subtypes.
Additionally, work with OR transgenes that experience shifts in zonal representation suggests the
presence and influence of zone-specific genomic loci and thus the presence of OSN subtypes 93,131,147.
The OSN representation of an OR spans the olfactory turbinates and is associated with at least one
glomerulus per half-bulb, thus an OSN will associate with one of the two glomeruli; these two
subpopulations of OSNs are not intermixed and are found in distinct regions of the epithelium, providing a
road towards evolutionary divergence92. These results are in line with the idea that precursor cells with
restricted OR-expression potential seed the epithelium during early nasal cavity development, replicate
laterally to generate more precursor cells and reproducibly separate from sister cells as the epithelium
keeps expanding.
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1.21 Models of Singularity
The singular expression of ORs is one of the major mechanistic mysteries of the olfactory system.
In general, mechanisms for singularity need to explain how a potential OR gene pool of hundreds or
thousands is restricted to high-level expression of one OR allele from only one OR gene. All explanations
must take into account that the OR promoter appears to be the gateway to stochastic, zone-specific,
glomerular domain-restricted OSN expression and that the expression of an OR or a surrogate OR from
that promoter is necessary to prevent other OR loci from activating. Thus, a two-phase process is
proposed with activation of an OR promoter followed by OR protein-mediated restriction of all other OR
promoters.
1) Dr. Stavros Lomvardas, his research group, and his associates spearhead one model of
singularity7,49,144,151,152,159–168. Their model is based on the formation of a multi-chromosomal OR Enhancer
hub that associates with one LSD1-activated OR promoter from a repertoire of aggregated and silenced
OR loci (Fig. 20). OR mRNA translation into OR protein triggers the Unfolded Protein Response in the
Endoplasmic Reticulum that activates a recovery cascade by blocking global translation and promoting
chaperone and Adenylate Cyclase III expression. This response represses LSD1 expression, suppresses
secondary derepressed loci and ultimately restricts the activation of additional OR loci, thus generating
singular OR expression. OR activity might further reinforce singularity169.

Fig. 20. A simplified version of the Enhancer Hub model for
Singularity. A model for essential and redundant functions of an
OR enhancer in cis and in trans respectively. Schematic
representations of different states in the OSN nucleus (left) and
corresponding transcriptional outputs (right). An OR gene (orange
box) located proximal to an enhancer (orange circle) is repressed
by H3K9me3 (red flag). The cis-proximal enhancer may facilitate
derepression of the OR chromatin landscape (green flag) but is not
sufficient for OR transcription. Multiple trans-interacting enhancers
(colored circles) aggregate around the transcribed cis-proximal OR
(orange box). Image and Modified Caption Source: MarkenscoffPapdimitriou, et al (2014)151.

Fig. 21. The proposed linked between OR-initiated signaling,
axon identity, glomerular position, and homotypic
convergence. Axon sorting of olfactory sensory neurons (OSNs) in
olfactory map formation. Differential utilization of cAMP signals for 20
global versus local axon sorting. In the mouse olfactory system,
axon-sorting molecules can be categorized into two different types:
type I (left) and type II (right). Type I molecules are expressed at
axon termini of immature OSNs in a graded manner along the
anterior-posterior (A-P) axis in the olfactory bulb (OB) and regulate
A-P positioning of glomeruli. In contrast, type II molecules are
expressed at axon termini of mature OSNs, showing a mosaic
pattern in the glomerular map, and are involved in glomerular

2) Evidence suggests that multiple OR loci can be activated in immature OSNs and the Enhancer
Hub model does not explain why additional hubs cannot be generated. Dr. Paul Feinstein proposes an
alternative interpretation to published research and the singularity problem. In this model, the OSN
nucleus generates a proteinaceous nuclear body that links the activation and transcription of an OR
promoter with a feedback or feedforward step triggered by OR protein generation at the Endoplasmic
Reticulum (ER) membrane. The nuclear bodies are distinct from the Lomvardas hubs since DNA is not
assigned a role in generating the nuclear body. The exact mechanism that links translation and feedback
is unknown, but the model postulates that successful OR translation will improve the nuclear body binding
kinetics and keep the first OR promoter associated with the nuclear body to the exclusion of other OR
loci. Failure to trigger the ER-based feedback due to the production of non-OR protein or failure to
translate OR protein will eventually release the OR promoter and a second OR locus will associate with
the nuclear body. The feedback likely involves a fast kinetics response in order to lock in the first
appropriate OR locus that interacts with the nuclear body. In this model, the data that lead to the
Lomvardas model is interpreted as the consequence of the high affinity between OR Enhancers and the
nuclear body, rather than an OR Enhancer-based prerequisite for generating a singularity-associated
transcriptional structure.
3) Dr. Peter Mombaerts proposed a third mechanism for singularity170. A statistical model, it
suggests that a feedback mechanism is not necessary, but rather that immature OSNs have some
probability of expressing zero, one, two, or more OR promoters. OSNs will degenerate if they fail to
express an OR either due to lack of OR promoter activation or due to expressing a non-OR protein. OSNs
that express at least one OR will mature, but the expression of two or more OR protein species would
likely be detrimental to axon identity and de novo glomerular formation. Thus, OSNs that fail to express
one OR are likely to degenerate, but this still leaves behind millions of OSNs that express ORs in
singularity.

1.22 Models of Glomerular Formation
The singular expression of ORs in OSNs is strongly associated with homotypic axon aggregation
and homogeneous glomeruli formation. The connection between the OR protein and these axonal
properties is hotly contested in the field, and falls into two camps: 1) differences in OR-derived signaling
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generate differential guidance protein expression profiles that localize axons expressing the same
receptor to the same bulbar location; 2) differences in OR protein structure mediate axon identity with
homotypic axon interactions preferential to heterotypic interactions, thus producing sorted projections.

Fig. 21. The proposed linked between OR-initiated signaling, axon identity, glomerular position, and homotypic
convergence. Axon sorting of olfactory sensory neurons (OSNs) in olfactory map formation. Differential utilization of cAMP
signals for global versus local axon sorting. In the mouse olfactory system, axon-sorting molecules can be categorized into
two different types: type I (left) and type II (right). Type I molecules are expressed at axon termini of immature OSNs in a
graded manner along the anterior-posterior (A-P) axis in the olfactory bulb (OB) and regulate A-P positioning of glomeruli. In
contrast, type II molecules are expressed at axon termini of mature OSNs, showing a mosaic pattern in the glomerular map,
and are involved in glomerular segregation. Expression of both type I and type II genes is regulated by odorant receptor
(OR)-derived cAMP signals. Each OR generates a unique level of cAMP with the aid of G protein and ACIII. The level of
cAMP signals in immature OSNs is converted into a relative expression level of type I molecules, e.g., Nrp1 and Sema3A, via
cAMP-dependent PKA and CREB (Imai et al. 2006). In mature OSNs, different ORs generate different neuronal activities that
determine the expression levels of axon-sorting molecules necessary for glomerular segregation, e.g., Kirrel2/3 and
EphA/ephrin-A (Serizawa et al. 2006). Image and Figure Caption Source: Mori & Sakano (2011)13.

1) Axon pathfinding via differential guidance cues is a common feature of nervous system
development and makes the mechanism an appealing explanation for OSN axon properties171,172. The

Fig. 22. Axon-sorting molecules in the olfactory bulb appear distributed throughout glomeruli without any
immediately evident pattern. While the differentially marked glomeruli are striking, the distribution of various axons-sorting
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(OB) and regulate A-P positioning of glomeruli. In contrast, type II molecules are expressed at axon termini of mature OSNs,
showing a mosaic pattern in the glomerular map, and are involved in glomerular segregation. Expression of both type I and
type II genes is regulated by odorant receptor (OR)-derived cAMP signals. Each OR generates a unique level of cAMP with
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the aid of G protein and ACIII. The level of cAMP signals in immature OSNs is converted into a relative expression level of
type I molecules, e.g., Nrp1 and Sema3A, via cAMP-dependent PKA and CREB (Imai et al. 2006). In mature OSNs, different
ORs generate different neuronal activities that determine the expression levels of axon-sorting molecules necessary for
glomerular segregation, e.g., Kirrel2/3 and EphA/ephrin-A (Serizawa et al. 2006). Image and Figure Caption Source: Mori &
Sakano (2011)13.

the G-Protein-based signal cascade at low frequency. cAMP is a prolific secondary messenger and can
trigger changes in gene expression through CREB activity and via local depolarization. The model
proposes that each OR has a fairly unique basal activity that tunes the expression of sorting-associated
genes, backed by experiments that manipulate cAMP levels and result in shifted glomerular position 173,179.
The mechanism involves two cAMP cascades, one acting through cAMP-associated cytoplasmic proteins
in the immature OSN, and the second approach via cAMP-mediated depolarization in mature OSNs, both
of which modulate the expression of specific sorting molecules, which translates into unique axonal
properties.
2) The structure-based model for axon identity is passively supported by the numerous signalingdeficient experiments that argue against the necessity of signaling in the process of glomerular formation:
CNG deletion180–183; various Gα subunits KOs56,79,184; Ggamma13 KO185; Adenylyl Cyclase III
deletion85,174,186; reduced signaling187. A curious feature of signaling deficiency is that its effects are most
prominent when only subsets of the OSN populations are affected and introducing signaling alternatives
improves these defects, suggesting a role of signaling in environment-dependent survival79,173,183. The
signaling model might reasonably predict that two neighboring OSNs with the same level of signaling
would converge their axons, regardless of the structure of the associated OR. This does not appear to be
the case: OSNs expressing two different ORs from the same locus, each with the same signaling
mutation supplemented with identical cAMP levels via constitutive Gα activity, do not converge together as
would be predicted by the signaling model79. Suggestively, despite the apparent influence of axon-sorting
molecules, their haphazard distribution throughout glomeruli makes it difficult to identify a functional
pattern188,189 (Fig. 22).
The structural model for axon identity suggests that cadherins or similar proteins interpret the
physicochemical properties of the OR and membranes with the same interpretation will preferentially
converge together. The presence of ORs throughout the entirety of the OSN, including the axons, is
suggestive of the direct role of OR protein in axonal sorting190–193. Modifying the amino acid sequence of
an OR, even a single residue, can lead to the formation of novel glomeruli that segregate from glomeruli
marked by the original OR protein76. The mechanisms behind this process are somewhat subtle as
certain modifications will only partially segregate glomeruli, but this partial segregation suggests that a
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threshold of OSN identity divergence is required for two ORs to generate two distinct glomeruli.
Furthermore, some GPCRs can generate adhesion properties in a homotypic-biased manner194,195, thus
the structure-based model is not without merit.
Though the structure-based model states that the capacity of an OR to signal appears to be
distinct from its role in the segregation of glomeruli, signaling still plays a role in the quantity and quality of
the projections. The “identity” of an OSN is more likely a cumulative readout of all the factors, notably the
expressed OR with its specific structural and signaling influences, but also the properties of the OSN
subtype that gives rise to that specific OR.

Fig. 22. Axon-sorting molecules in the olfactory bulb appear distributed throughout glomeruli without any immediately
evident pattern. While the differentially marked glomeruli are striking, the distribution of various axons-sorting molecules is
likely a byproduct of the OSN subtype and expressed OR gene, leading to the expression of some variable amount of each
axon-sorting molecule, which can then contribute to axon segregation and congregation. A combinatorial approach to sorting
instead of a gradient-based positioning system can account for the lack of pattern. Image Sources: A. Ihara, et al (2016) 187. B.
Nakashima, et al (2019)188.

Fig. 23. MouSensors aka “High Representation” transgenes take advantage of endogenous genetic elements to
improve the number of OSNs that express a specific OR. A. Top. Structure of the HR transgenes used in this thesis. Bottom.
The “P” and “H” elements are the origin of the multimerized homeodomain sequence “x21”. nx21: number of 21bp
homeodomain repeats. TSS: transcription start site. OR CDS: Odorant Receptor Coding Sequence. IRES: Internal Ribosome
Entry Site. B. The homeodomain sequence rests within a 21bp core in order to align the binding sites and theoretically improve
binding; previous efforts with 19bp sequences were less successful. C. An example of an HR transgene at work. With four x21 24
repeats, the OR M71 is expressed in tens of thousands of OSNs in the Main Olfactory Epithelium (MOE) and produces large,
robust glomeruli in the Main Olfactory Bulbs (MOB). Image Source: D’hulst, et al (2016)154.Fig. 22. Axon-sorting molecules in
the olfactory bulb appear distributed throughout glomeruli without any immediately evident pattern. While the
differentially marked glomeruli are striking, the distribution of various axons-sorting molecules is likely a byproduct of the OSN
subtype and expressed OR gene, leading to the expression of some variable amount of each axon-sorting molecule, which can
then contribute to axon segregation and congregation. A combinatorial approach to sorting instead of a gradient-based
positioning system can account for the lack of pattern. Image Sources: A. Ihara, et al (2016) 187. B. Nakashima, et al (2019)188.

1.23 High Representation Constructs
The H element appears to be a powerful tool in regulating the representation of cis OR
genes70,127,147,149,150. Inserting a multimerized homeodomain sequence from the H element upstream of an
OR transgene increased OSN representation for that OR147. Refined further, this multimer approach was
used to generate consistent high-level representation of an OR transgene, called a MouSensor or a High
Representation (HR) transgene155 (Fig. 23). These transgenes mimic the zonality of the core M71
promoter, form homogeneous glomeruli, and associate with endogenous OSN axons with the same OR
identity. Changing protein levels, structure, or functionality would affect convergence properties76,79,136.

Fig. 23. MouSensors aka “High Representation” transgenes take advantage of endogenous genetic elements to
improve the number of OSNs that express a specific OR. A. Top. Structure of the HR transgenes used in this thesis.
Bottom. The “P” and “H” elements are the origin of the multimerized homeodomain sequence “x21”. nx21: number of 21bp
homeodomain repeats. TSS: transcription start site. OR CDS: Odorant Receptor Coding Sequence. IRES: Internal
Ribosome Entry Site. B. The homeodomain sequence rests within a 21bp core in order to align the binding sites and
theoretically improve binding; previous efforts with 19bp sequences were less successful. C. An example of an HR
transgene at work. With four x21 repeats, the OR M71 is expressed in tens of thousands of OSNs in the Main Olfactory
Epithelium (MOE) and produces large, robust glomeruli in the Main Olfactory Bulbs (MOB). Image Source: D’hulst, et al
(2016)154.

Thus despite the increased representation, HR constructs are likely activated using the
Fig. 24. Modular transgenic systems provide a means for broad and rapid production of gene expression in
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within a 21bp core in order to align the binding sites and theoretically improve binding; previous efforts with 19bp
sequences were less successful. C. An example of an HR transgene at work. With four x21 repeats, the OR M71 is
expressed in tens of thousands of OSNs in the Main Olfactory Epithelium (MOE) and produces large, robust glomeruli in
the Main Olfactory Bulbs (MOB). Image Source: D’hulst, et al (2016)154.
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1.24 The tTA/TetO Expression System
In order to study the expression of a particular gene in a particular tissue, a tissue-specific
promoter needs to be associated with a gene of interest. The value of a modular gene expression system,
in which the two necessary elements are part of different genetic constructs, is in the ability to easily
generate novel expression patterns without the need to generate new transgenic animals. Two wellknown examples are the GAL4/UAS196,197 and tTA/TetO systems198–200 (Fig. 24). A tissue-specific
promoter is used to drive transcription of an activator protein, GAL4 or tTA, which will bind a multimerized
promoter sequence, UAS or TetO, respectively, thus activating transcription of a gene of interest. Though
not restricted in usage, the GAL4/UAS system is typically used in D. melanogaster, while tTA/TetO is
used within mammalian tissue and is ubiquitously used in this thesis.

Fig. 24. Modular transgenic systems provide a means for broad and rapid production of gene expression in specific
tissues. A. The GAL4/UAS system uses a tissue-specific enhancer to drive the expression of the yeast GAL4 transcriptional
activator, which binds to the Upstream Activating Sequence (UAS) of a second gene, driving the transcription of Gene X in the
specific tissue. Commonly used in fruit flies, and occasionally with a controllable GAL4 variant, this system allows for rapid
production of desired tissue-specific gene expression. Image Source: Kelly, et al (2017)196. B. The tTA/TetO system is
analogous to the GAL4/UAS system, with a tissue-specific promoter driving the expression of tTA, which binds to TetO
sequences and promotes the transcription of the linked gene. The tTA protein and its variant rtTA can be regulated by
tetracycline or doxycycline. Image Source: https://www.genoway.com/technologies/tet/tet-system.htm

The tTA protein is a chimera composed of the activation domain of the Herpes Simplex Virus
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constructs201, echoing the required caution when using tTA/TetO to study gene expression202,203.
Fig. 24. Modular transgenic systems provide a means for broad and rapid production of gene expression in specific
tissues. A. The GAL4/UAS system uses a tissue-specific enhancer to drive the expression of the yeast GAL4 transcriptional
activator, which binds to the Upstream Activating Sequence (UAS) of a second gene, driving the transcription of Gene X in the
specific tissue. Commonly used in fruit flies, and occasionally with a controllable GAL4 variant, this system allows for rapid
production of desired tissue-specific gene expression. Image Source: Kelly, et al (2017)196. B. The tTA/TetO system is
analogous to the GAL4/UAS system, with a tissue-specific promoter driving the expression of tTA, which binds to TetO
sequences and promotes the transcription of the linked gene. The tTA protein and its variant rtTA can be regulated by
tetracycline or doxycycline. Image Source: https://www.genoway.com/technologies/tet/tet-system.htm
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1.25 tTA/TetO in the Olfactory System
The use of the modular gene expression system tTA/TetO to drive the transcription of ORs in
OSNs is subject to transgene position effects with variable OSN representation from different founder
mouse lines133. Contrary to other non-OR promoters, the TetO promoter in tandem with the tTA activator
will express an OR in apparent singularity134,204. Two differentially marked TetO-OR alleles will also be
expressed in exclusion to each other205. Related to this suppression result, genomes containing
increasingly more repeats of the TetO promoter will produce decreasingly less mRNA or protein per
promoter203,206. The VP16 protein, used in the construction of tTA, normally associates with host proteins,
inhibits host cell translation, and generates expression of HSV genes 207,208. The similarities between
endogenous OR expression, the tTA/TetO expression system, and how tTA/TetO functions in OSNs
suggests that this gene expression system mimics, integrates into or dominates the endogenous OR
singularity mechanism.

1.26 Research Results Primer
The impetus for my research was the need to understand how tTA/TetO transgenes affect the
singularity mechanism. The OMP and CAM promoters that were used to drive tTA expression are active
after the OSN begins OR expression and are considered markers for maturing OSNs82,209,210. If the
expression of an endogenous OR gene is the trigger for feedback or feedforward, how is it that
expressing TetO-OR using OMP-tTA or CAM-tTA disrupts endogenous OR gene expression, which
already weathered the feedback 134,204? Using GNG8-tTA to drive TetO-OR expression also seems to
promote singularity133,211. The issue lies with the fact that the GNG8 gene is a marker of immature OSNs
and is not expressed in the mature OSN, so what exactly is happening in those TetO-OR-expressing
OSNs? The High Representation (HR) constructs, which theoretically act via the endogenous singularity
mechanism, provide an efficient means of observing the impact of tTA/TetO on ORs and OSNs.
Strikingly, my data reveals that TetO transgenes are subject to HR-mediated suppression,
leading to reduced TetO signal in HR OSNs. Based on these results and several related experiments, I
propose the existence of a context-dependent nuclear activation hierarchy as a consequence of the
limited high-level transcription that an OSN can support, culminating with the idea of a singular structure
for OR gene transcription called the Olfaction Body.
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Chapter 2: Results Part 1
TetO Expression is reduced in HR-Positive OSNs
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Despite several decades of research and experimentation, the Olfactory System is still something
of a mystery, but I believe we are close to unveiling its secrets. In my in vivo dissection of this system, I
tested a number of transgenic constructs in order to identify how they affect OSN properties and how
OSN properties impact these transgenes (Fig. 25). The genotype for each image is located above the
image and the signal source is noted inside the image. My first collection of results suggests that HR
transgene expression is adequate to suppress, though not completely eliminate, TetO expression in HRpositive OSNs.

Fig. 25. Constructs used in this thesis. Left column identifies the construct as Gene-Targeted (GT) to the locus associated
with the promoter or as Transgenic (Tg) if the site of integration is not a specific target locus. Abbreviation for each construct are
listed and used throughout this document. Use this figure and the Table of Abbreviations & Definitions as reference.

Fig. 25. Constructs used in this thesis. Left column identifies the construct as Gene-Targeted (GT) to the locus associated
with the promoter or as Transgenic (Tg) if the site of integration is not a specific target locus. Abbreviation for each construct are
listed and used throughout this document. Use this figure and the Table of Abbreviations & Definitions as reference.
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Fig. 25. Constructs used in this thesis. Left column identifies the construct as Gene-Targeted (GT) to the locus associated
with the promoter or as Transgenic (Tg) if the site of integration is not a specific target locus. Abbreviation for each construct are
listed and used throughout this document. Use this figure and the Table of Abbreviations & Definitions as reference.

2.1 HR-OR OSNs are biased against TetO-OR expression
The literature claims that the expression of an OR via the tTA/TetO system is adequate to
suppress endogenous OR gene expression204,205. The suggested mechanism is through the feedback
step of OR singularity via the exogenous expression of an OR gene, circumventing the endogenous
activation step. The HR (High Representation) transgenes used in this thesis contain the same DNA
elements as endogenous OR genes and are proposed to efficiently generate singularity via the
endogenous mechanism. Thus, it would be reasonable to assume that TetO-OR expression via CAM-tTA
or OMP-tTA, the two tTA transgenes used in the referenced literature, will trigger the feedback step and
visibly disrupt HR expression. As suggested in Section 1.26, the timing of CAM and OMP expression in
OSN development is similar, and thus data obtained from the two tTA driver lines is grouped together.

Fig. 26. TetO-M71 signal is broadly distributed across the Olfactory Bulb surface and Olfactory Epithelium. Genotype:
CAM-tTA/TetO-M71. A. TetO-M71 signal via X-gal staining. Olfactory Turbinate Dissection. Adult mouse. This is the Medial
view. The Dorsal/Ventral and Anterior/Posterior Axes are displayed. B. TetO-M71 signal via Anti-βgal+AF647 antibodies.
Olfactory Bulb Dissection. 43-day-old male mouse. Scale bar: 500 μm. The Medial/Lateral and Anterior/Posterior Axes are
displayed. C. TetO-M71 signal via Anti-βgal+AF488 antibodies. Epithelial Section. 33-day-old female mouse. Scale bar: 100
μm.

Firstly, though TetO-M71 (TetO-M71 IRES tauLacZ) expression via CAM-tTA is not entirely
Fig. 26. TetO-M71 signal is broadly distributed across the Olfactory Bulb surface and Olfactory Epithelium. Genotype:
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Fig. 26. TetO-M71 signal is broadly distributed across the Olfactory Bulb surface and Olfactory Epithelium. Genotype:
CAM-tTA/TetO-M71. A. TetO-M71 signal via X-gal staining. Olfactory Turbinate Dissection. Adult mouse. This is the Medial
view. The Dorsal/Ventral and Anterior/Posterior Axes are displayed. B. TetO-M71 signal via Anti-βgal+AF647 antibodies.
Olfactory Bulb Dissection. 43-day-old male mouse. Scale bar: 500 μm. The Medial/Lateral and Anterior/Posterior Axes are
displayed. C. TetO-M71 signal via Anti-βgal+AF488 antibodies. Epithelial Section. 33-day-old female mouse. Scale bar: 100
μm.

Fig. 27. 5O glomeruli are not eliminated due to CAM-tTA/TetO-M71 expression. A. Genotype: 5O. 5O signal via tauCherry.
Olfactory Turbinate Dissection. 38-day-old male mouse. Scale bar: 500 μm. B. Genotype: 5O. 5O signal via tauCherry.
Olfactory Bulb Dissection. 45-day-old male mouse. Scale bar: 500 μm. C. Genotype: 5O/CAM-tTA/TetO-M71. 5O signal via
tauCherry. Olfactory Bulb Dissection. 70-day-old male mouse. Scale bar: 500 μm.
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which further supports the observation that HR-OR OSNs have reduced TetO-OR signal (Fig. 30).
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Fig. 28. HR-OR glomeruli have significantly less TetO-M71 signal than surrounding glomeruli. A: Genotype: M71GFP/5O/OMP-tTA/TetO-M71. M71-GFP is not explored in this figure. 5O signal via tauCherry. TetO-M71 signal via Antiβgal+AF647 antibodies. Bulb Section. 34-day-old male mouse. Arrowheads point to 5O glomeruli. Scale bar: 500 μm. Inset:
Zoom of merge channel, 5O glomeruli. Scale bar: 50 μm. B. Scatterplots showing the TetO-M71 signal via Anti-βgal antibody
found in HR-OR glomeruli and non-HR-OR glomeruli obtained from three different samples. An unpaired t-test for each sample
was significant to different degrees. Black lines are the means.
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Zoom of merge channel, 5O glomeruli. Scale bar: 50 μm. B. Scatterplots showing the TetO-M71 signal via Anti-βgal antibody
found in HR-OR glomeruli and non-HR-OR glomeruli obtained from three different samples. An unpaired t-test for each sample 32
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Fig. 28. HR-OR glomeruli have significantly less TetO-M71 signal than surrounding glomeruli. A: Genotype: M71-

Fig. 29. HR-OR OSNs have less TetO-M71 signal than non-HR-OR OSNs. A: Genotype: M71-GFP/5O/OMP-tTA/TetO-M71.
M71-GFP is not explored in this figure. 5O signal via tauCherry. TetO-M71 signal via Anti-βgal+AF647 antibodies. Epithelial
Section. 34-day-old male mouse. Scale bar: 50 μm. B. Scatterplot showing TetO-M71 signal via Anti-βgal antibody found in HROR OSNs and non-HR-OR OSNs obtained from pooling seven different sample sets from three different animals. An unpaired ttest was significant. Black lines are the mean.
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Fig. 29. HR-OR OSNs have less TetO-M71 signal than non-HR-OR OSNs. A: Genotype: M71-GFP/5O/OMP-tTA/TetO-M71.

Fig. 30. TetO-P2 produces similar results to TetO-M71 in HR-OR glomeruli and OSNs. A,C. Genotype: 5O/CAM-tTA/TetOP2. 5O signal via tauCherry. TetO-P2 signal via GFP. A. Olfactory Bulb Dissection. 76-day-old female mouse. Scale bar: 500
μm. B. Scatterplot showing TetO-P2 signal via GFP in HR-OR glomeruli and in TetO-P2 glomeruli obtained from pooling
measurements from four different animals. An unpaired t-test was significant. Black lines are the means. C. Olfactory Turbinate
Dissection. 36-day-old mouse. Scale bar: 100 μm. D. Scatterplot showing TetO-P2 signal via GFP in 5O OSNs and in TetO-P2
OSNs obtained from C. An unpaired t-test was significant. Black lines are the means.

How are these two transgenic systems generating this restricted expression pattern? One
possible explanation is that the two systems are expressed in somewhat exclusive OSN subpopulations,
Fig. 30. TetO-P2 produces similar results to TetO-M71 in HR-OR glomeruli and OSNs. A,C. Genotype: 5O/CAM-tTA/TetOP2. 5O signal via tauCherry. TetO-P2 signal via GFP. A. Olfactory Bulb Dissection. 76-day-old female mouse. Scale bar: 500
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genes; though requiring confirmation, it is likely HR OSNs express these two genes. More tangibly, 4M
(4x21 M71 IRES tauCherry) OSNs are positive for the tTA protein detected with an Anti-VP16 antibody
Fig. 30. TetO-P2 produces similar results to TetO-M71 in HR-OR glomeruli and OSNs. A,C. Genotype: 5O/CAM-tTA/TetO-
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difficult to distinguish 5O glomerular signal, the recombination product marks much of the Olfactory Bulbs
(Fig. 31C). In combination with the fact that at least some TetO-OR signal is evident in HR-OR OSNs, it is
less
likely that exclusive OSN subpopulations can explain the reduced TetO-M71 expression.
Fig. 30. TetO-P2 produces similar results to TetO-M71 in HR-OR glomeruli and OSNs. A,C. Genotype: 5O/CAM-tTA/TetOP2. 5O signal via tauCherry. TetO-P2 signal via GFP. A. Olfactory Bulb Dissection. 76-day-old female mouse. Scale bar: 500
μm. B. Scatterplot showing TetO-P2 signal via GFP in HR-OR glomeruli and in TetO-P2 glomeruli obtained from pooling
measurements from four different animals. An unpaired t-test was significant. Black lines are the means. C. Olfactory Turbinate
Dissection. 36-day-old mouse. Scale bar: 100 μm. D. Scatterplot showing TetO-P2 signal via GFP in 5O OSNs and in TetO-P2
OSNs obtained from C. An unpaired t-test was significant. Black lines are the means.
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Fig. 30. TetO-P2 produces similar results to TetO-M71 in HR-OR glomeruli and OSNs. A,C. Genotype: 5O/CAM-tTA/TetOP2. 5O signal via tauCherry. TetO-P2 signal via GFP. A. Olfactory Bulb Dissection. 76-day-old female mouse. Scale bar: 500
μm. B. Scatterplot showing TetO-P2 signal via GFP in HR-OR glomeruli and in TetO-P2 glomeruli obtained from pooling
measurements from four different animals. An unpaired t-test was significant. Black lines are the means. C. Olfactory Turbinate

Fig. 31. TetO expression is transient in 5O OSNs despite the presence of tTA protein. A. tTA protein is present in 4M
OSNs. Genotype: 4M/OMP-tTA/TetO-M71. 4M signal via tauCherry. OMP-tTA signal via Anti-VP16+AF488 antibodies.
Epithelial Section. 31-day-old male mouse. Scale bar: 100 μm. B,C. 5O OSNs are positive for at least transient TetO-Cre
activity, which permanently marks OSNs as MG-positive via excision of MT and a stop codon. Genotype: 5O/OMP-tTA/TetOCre/ROSA-MTMG. ROSA-MG signal via cre-dependent membraneGFP (MG). 5O signal via tauCherry. ROSA-MTMG signal via
non-recombined membraneTomato (MT). Adult male mouse. B. tauCherry signal is distinguished from MT signal by the
presence of cytoplasmic signal vs. membrane-only signal for MT. Epithelial Section. Scale bar: 100 μm. C. tauCherry signal is
not distinguishable from MT signal, but MG signal is found in much of the bulb. Olfactory Bulb Dissection. Scale bar: 500 μm.

Fig. 31. TetO expression is transient in 5O OSNs despite the presence of tTA protein. A. tTA protein is present in 4M
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OSNs. Genotype: 4M/OMP-tTA/TetO-M71. 4M signal via tauCherry. OMP-tTA signal via Anti-VP16+AF488 antibodies.
Epithelial Section. 31-day-old male mouse. Scale bar: 100 μm. B,C. 5O OSNs are positive for at least transient TetO-Cre
activity, which permanently marks OSNs as MG-positive via excision of MT and a stop codon. Genotype: 5O/OMP-tTA/TetOCre/ROSA-MTMG. ROSA-MG signal via cre-dependent membraneGFP (MG). 5O signal via tauCherry. ROSA-MTMG signal via
non-recombined membraneTomato (MT). Adult male mouse. B. tauCherry signal is distinguished from MT signal by the
presence of cytoplasmic signal vs. membrane-only signal for MT. Epithelial Section. Scale bar: 100 μm. C. tauCherry signal is
not distinguishable from MT signal, but MG signal is found in much of the bulb. Olfactory Bulb Dissection. Scale bar: 500 μm.

An easy culprit to blame for the reduced TetO-M71 signal is the presence of an OR sequence in
the TetO transgene. The suggested mechanism involves the HR-OR transgene triggering the singularity
feedback, shutting down OR coding sequence-containing genes like TetO-M71. As part of the proposed
explanation, CAM-tTA and OMP-tTA generate TetO-M71-based OR gene singularity because the TetOM71 transgene activates before endogenous OR genes, which is an unsupported claim. If as such, HROR transgenes suppress TetO-ORs by activating even earlier. The problem with this solution is that the
exclusive phenomenon is still apparent when TetO-OR transgenes are replaced with TetO constructs that
lack all OR gene elements, and should not be subject to any OR-specific feedback. Section 2.2 contains
the experiments supporting this claim.

2.2 TetO transgenes without OR gene elements experience HR-OR-mediated
interference
If the entire means by which TetO-OR transgenes interact with the singularity mechanism is via
their OR coding sequence, then TetO transgenes without OR coding sequences should be expressed
equally in HR-OSNs and non-HR-OSNs. The expression of TetO-tauLacZ via OMP-tTA or CAM-tTA is
very similar to TetO-M71, with broad Beta-galactosidase present in the epithelium and bulbs (Fig. 32).

Fig. 32. TetO-tauLacZ signal densely marks the olfactory epithelium and olfactory bulbs. A. Genotype: OMP-tTA/TetOtauLacZ. TetO-tauLacZ signal via X-gal staining. Olfactory Bulb Dissection. Adult mouse. B,C. Genotype: CAM-tTA/TetOtauLacZ. B. TetO-tauLacZ signal via X-gal staining. Olfactory Bulb Dissection. Adult mouse. C. TetO-tauLacZ signal via Antiβgal+AF647 antibodies. Olfactory Bulb Dissection. 37-day-old male mouse. Scale bar: 500 μm.
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Fig. 33. The absence of an OR coding sequence downstream of TetO does not rescue the transgene from HR-ORassociated exclusion. A,C. Genotype: 5M/CAM-tTA/TetO-tauLacZ. 5M signal via tauCherry. TetO-tauLacZ via Antiβgal+AF488 antibodies in A and AF647 in C. A. Bulb Section. Adult female mouse. Scale bar: 50 μm. B. Scatterplot showing
TetO-tauLacZ signal via Anti-βgal antibody in 5M and TetO-tauLacZ glomeruli obtained from pooling measurements from four
animals. An unpaired t-test was significant. Black lines are the means. C. Epithelial Section. 33-day-old male mouse. Scale bar:
100 μm. D. Scatterplot showing TetO-tauLacZ signal via Anti-βgal antibody in 5M and TetO-tauLacZ OSNs obtained from
pooling six samples from three animals. An unpaired t-test was significant. Black lines are the means. E. Genotype: 5O/CAMtTA/TetO-GFPLacZ. 5O signal via tauCherry. TetO-GFPLacZ signal via GFP. The LacZ signal was not investigated in this
animal. Olfactory Bulb Dissection. 21-day old mouse. Scale bar: 500 μm. F. Scatterplot showing TetO-GFPLacZ signal via GFP
in 5O glomeruli and TetO-GFPLacZ glomeruli obtained from pooling two groups of measurements from one animal. An unpaired
t-test was significant. Black lines are the means.

In the context of the HR-OR construct 5M (5x21 M71 IRES tauCherry), the “equal expression”
hypothesis is not supported and the outcome is in line with the earlier TetO-OR data. 5M glomeruli have
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GFPLacZ transgene has reduced presence in the 5O glomeruli (Fig. 33E,F). The absence of OR genespecific components in these TetO transgenes makes any mechanism that invokes these components to
explain the reduced TetO signal in HR-OR OSNs unacceptable. Additionally, the TetO-tauLacZ and TetOGFPLacZ transgenes are incapable of suppressing HR-ORs, putting that possible explanation for
mutually exclusive expression to rest.
The reduced or absent TetO expression in HR-OR OSN structures might be explained by the
absence of tTA protein in HR-OR OSNs, but this is not the case as tTA protein is present in those cells
(Fig. 31A). Thus, the target of the HR-OR-mediated suppression of TetO expression is likely the TetO
transgene itself and not the tTA driver lines. The presence of some Beta-galactose signal in HR-OR
OSNs does suggest that the suppressive effect is incompletely dominant. This is further supported by
TetO-Cre-induced recombination of the ROSA-MTMG lineage tracer and consequent expression of the
recombined marker gene in 5O OSNs (Fig. 31B); it doesn’t take much cre recombinase to mark cells,
thus TetO-Cre is at least transiently active in 5O OSNs. Despite the apparent lack of common elements, it
appears as though HR-ORs and TetO transgenes compete with each other for expression in OSNs with
HR-ORs coming out on top in the CAM-tTA or OMP-tTA contexts.

2.3 5O resists the impact of TetO-Diphtheria Toxin expression
My results thus far suggest that HR-OR transgene expression can reduce the amount of TetO
expression in the same OSN. If this is in fact the case, the expression of 5O transgene in an OSN should
improve the survival of that OSN in the context of OSN-specific TetO-Toxin (TetO-Diphtheria Toxin A)
expression, which codes for a translational repressor that leads to cell death212,213. In addition, the use of
a translational toxin would help address the question of how HR-ORs mediate their impact on TetO
transgenes. How robust is the need for OR translation-mediated feedback to explain the observed
phenomenon? Though dissecting the results is not clear-cut due to the self-interacting nature of TetOToxin expression, the 5O transgene seems to bear the burden of TetO-Toxin better than non-5O OSNs.
In the presence of the OMP-tTA and TetO-Toxin constructs, the olfactory bulbs are significantly
smaller than in animals without active TetO-Toxin expression (Fig. 34). In the context of the 5O
transgene, the bulbs are still smaller in the TetO-Toxin background (Fig. 35).Without TetO-Toxin
expression, 5O axons converge into numerous glomeruli, which appear to be either in close proximity to
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each other or connected with additional 5O axons. The active TetO-Toxin transgene leads to 5O
glomeruli that are isolated and form from independent bundles, but the projections still resemble the 5O
control with axons projecting towards the posterior end of the bulb. More importantly, the tauCherry signal
from 5O is still present in the olfactory bulbs, meaning that TetO-Toxin didn’t eliminate 5O OSNs, which
supports my prediction that 5O can suppress TetO-Toxin.

Fig. 34. TetO-Diphtheria Toxin A expression in OSNs reduces the size of the Olfactory Bulbs. Bulb structure was
visualized by increasing autofluorescent saturation post-acquisition. Projection of dorsal bulb surface was outlined and used to
generate surface area values via ImageJ. Scale bar: 500 μm. A. Genotype: TetO-Toxin. Olfactory Bulb Dissection. 46-day-old
male mouse. B. Genotype: OMP-tTA/TetO-Toxin. Olfactory Bulb Dissection. 44-day-old male mouse. C. Scatterplot showing the
difference in the projected dorsal bulb surface area in square millimeters between animals that either did not express TetOToxin or did express TetO-Toxin. Outside this factor, each category contains mixed genotypes. An unpaired t-test was
significant. Each dot represents the total surface area of both bulbs in one animal. Blanks lines are the means.

Despite the published claims that TetO-M71 via CAM-tTA or OMP-tTA is expressed before
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visualized by increasing autofluorescent saturation post-acquisition. Projection of dorsal bulb surface was outlined and used to
generate surface area values via ImageJ. Scale bar: 500 μm. A. Genotype: TetO-Toxin. Olfactory Bulb Dissection. 46-day-old
male mouse. B. Genotype: OMP-tTA/TetO-Toxin. Olfactory Bulb Dissection. 44-day-old male mouse. C. Scatterplot showing the
difference in the projected dorsal bulb surface area in square millimeters between animals that either did not express TetOToxin or did express TetO-Toxin. Outside this factor, each category contains mixed genotypes. An unpaired t-test was
significant. Each dot represents the total surface area of both bulbs in one animal. Blanks lines are the means.
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Fig. 34. TetO-Diphtheria Toxin A expression in OSNs reduces the size of the Olfactory Bulbs. Bulb structure was
visualized by increasing autofluorescent saturation post-acquisition. Projection of dorsal bulb surface was outlined and used to
generate surface area values via ImageJ. Scale bar: 500 μm. A. Genotype: TetO-Toxin. Olfactory Bulb Dissection. 46-day-old
male mouse. B. Genotype: OMP-tTA/TetO-Toxin. Olfactory Bulb Dissection. 44-day-old male mouse. C. Scatterplot showing the
difference in the projected dorsal bulb surface area in square millimeters between animals that either did not express TetOToxin or did express TetO-Toxin. Outside this factor, each category contains mixed genotypes. An unpaired t-test was
significant. Each dot represents the total surface area of both bulbs in one animal. Blanks lines are the means.

Fig. 35. 5O projections are perturbed, but still present in the TetO-Toxin background. 5O signal via tauCherry. Olfactory
Bulb Dissection. Scale bar: 500 μm. A. Genotype: 5O. Left and Right Bulbs. Adult male mouse. B. Genotype: 5O/OMPtTA/TetO-Toxin. Left and Right Bulbs. 59-day-old male mouse.

The GNG8 gene is a marker of immature OSNS, and thus the GNG8-tTA construct is active in

Fig. 35. 5O projections are perturbed, but still present in the TetO-Toxin background. 5O signal via tauCherry. Olfactory
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epithelium214 (Fig. 36A). Using the early GNG8-tTA driver alongside the relatively late OMP-tTA driver
Fig. 35. 5O projections are perturbed, but still present in the TetO-Toxin background. 5O signal via tauCherry. Olfactory
Bulb Dissection. Scale bar: 500 μm. A. Genotype: 5O. Left and Right Bulbs. Adult male mouse. B. Genotype: 5O/OMPtTA/TetO-Toxin. Left and Right Bulbs. 59-day-old male mouse.

Fig. 35. 5O projections are perturbed, but still present in the TetO-Toxin background. 5O signal via tauCherry. Olfactory
Bulb Dissection. Scale bar: 500 μm. A. Genotype: 5O. Left and Right Bulbs. Adult male mouse. B. Genotype: 5O/OMPtTA/TetO-Toxin. Left and Right Bulbs. 59-day-old male mouse.
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should generate persistent TetO-Toxin expression. Remarkably, the activity of TetO-Toxin via both
GNG8-tTA and OMP-tTA does not produce obvious defects in the olfactory epithelium of a 29-day-old
animal. The mature OSN markers Adenylyl Cyclase III (AC3) and Golf are present throughout the apical
cilia layer and the epithelium looks dense with OSNs (Fig. 36B, 37A). In addition, Golf signal is evident in
the glomeruli of the olfactory bulb, further suggesting that OSNs are maturing (Fig. 37B). These results
also apply to the 5O OSNs, which are prominent, but not uniquely present in OSNs and glomeruli. Thus,
OSNs do mature and OSN axons do make it to the olfactory bulb.

Fig. 36. Introducing TetO-Toxin expression in immature OSNs does not produce epithelial defects in young mice. A.
Genotype: GNG8-tTA/TetO-tauLacZ. TetO-tauLacZ signal via Anti-βgal+AF647 antibodies. Epithelial Section. 32-day-old male
mouse. Scale bar: 100 μm. B. Genotype: 5O/GNG8-tTA/OMP-tTA/TetO-Toxin. 5O signal via tauCherry. AC3 signal via AntiAC3+AF488. 29-day-old female mouse. Epithelial Section. Scale bar: 100 μm.

Fig. 36. Introducing TetO-Toxin expression in immature OSNs does not produce epithelial defects in young mice. A.
Genotype: GNG8-tTA/TetO-tauLacZ. TetO-tauLacZ signal via Anti-βgal+AF647 antibodies. Epithelial Section. 32-day-old male
mouse. Scale bar: 100 μm. B. Genotype: 5O/GNG8-tTA/OMP-tTA/TetO-Toxin. 5O signal via tauCherry. AC3 signal via AntiAC3+AF488. 29-day-old female mouse. Epithelial Section. Scale bar: 100 μm.

Fig. 36. Introducing TetO-Toxin expression in immature OSNs does not produce epithelial defects in young mice. A.
Genotype: GNG8-tTA/TetO-tauLacZ. TetO-tauLacZ signal via Anti-βgal+AF647 antibodies. Epithelial Section. 32-day-old male
mouse. Scale bar: 100 μm. B. Genotype: 5O/GNG8-tTA/OMP-tTA/TetO-Toxin. 5O signal via tauCherry. AC3 signal via AntiAC3+AF488. 29-day-old female mouse. Epithelial Section. Scale bar: 100 μm.
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Fig. 36. Introducing TetO-Toxin expression in immature OSNs does not produce epithelial defects in young mice. A.
Genotype: GNG8-tTA/TetO-tauLacZ. TetO-tauLacZ signal via Anti-βgal+AF647 antibodies. Epithelial Section. 32-day-old male
mouse. Scale bar: 100 μm. B. Genotype: 5O/GNG8-tTA/OMP-tTA/TetO-Toxin. 5O signal via tauCherry. AC3 signal via AntiAC3+AF488. 29-day-old female mouse. Epithelial Section. Scale bar: 100 μm.

Fig. 37. One-month-old TetO-Toxin animals present a mature OSN marker throughout the epithelium and bulb in the
context of persistent tTA expression. Genotype: 5O/GNG8-tTA/OMP-tTA/TetO-Toxin. 5O signal via tauCherry. Golf signal via
Anti-Golf+AF488. 29-day-old female mouse. Scale bar: 100 μm. A. Epithelial Section. B. Bulb Section.

One possible factor explaining this observation is animal age, with published work that shows
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age213. In younger animals, TetO-Toxin might activate and lead to OSN death after the OSN matured, but
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context of persistent tTA expression. Genotype: 5O/GNG8-tTA/OMP-tTA/TetO-Toxin. 5O signal via tauCherry. Golf signal via
Anti-Golf+AF488. 29-day-old female mouse. Scale bar: 100 μm. A. Epithelial Section. B. Bulb Section.
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and maturation process that follows might overcome this barrier of translational inhibition.

Fig. 37. One-month-old TetO-Toxin animals present a mature OSN marker throughout the epithelium and bulb in the
context of persistent tTA expression. Genotype: 5O/GNG8-tTA/OMP-tTA/TetO-Toxin. 5O signal via tauCherry. Golf signal via
Anti-Golf+AF488. 29-day-old female mouse. Scale bar: 100 μm. A. Epithelial Section. B. Bulb Section.
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Fig. 37. One-month-old TetO-Toxin animals present a mature OSN marker throughout the epithelium and bulb in the
context of persistent tTA expression. Genotype: 5O/GNG8-tTA/OMP-tTA/TetO-Toxin. 5O signal via tauCherry. Golf signal via
Anti-Golf+AF488. 29-day-old female mouse. Scale bar: 100 μm. A. Epithelial Section. B. Bulb Section.

Fig. 37. One-month-old TetO-Toxin animals present a mature OSN marker throughout the epithelium and bulb in the
context of persistent tTA expression. Genotype: 5O/GNG8-tTA/OMP-tTA/TetO-Toxin. 5O signal via tauCherry. Golf signal via

Similar to the OMP-tTA context alone, the presence of GNG8-tTA and OMP-tTA driving TetOToxin will still allow 5O OSNs to generate projections that end in multiple distinct glomeruli and these
glomeruli persist in older animals (Fig. 38). These distinct glomeruli might represent independent OSN
subtypes that only become apparent in TetO-Toxin-expressing mice, perhaps due to reduced glomerular
background or amplification of subtype-specific variation. The 5O signal in older animals appears to
diminish, likely due to the loss of the epithelial regenerative capacity213 as a consequence of long-term
TetO-Toxin expression. Further analysis of OSN numbers in the epithelium can corroborate the claim of
5O OSN survival.

Fig. 38. 5O projections are present in older TetO-Toxin mice. Genotype: 5O/GNG8-tTA/OMP-tTA/TetO-Toxin. 5O signal via
tauCherry. Olfactory Bulb Dissection. Scale bar: 500 μm. A. 45-day-old male mouse. B. 87-day-old female mouse. C. 205-dayold male mouse.

The glomerular layer of the olfactory bulb is composed of spheroidal structures demarcated by

Fig. 38. 5O projections are present in older TetO-Toxin mice. Genotype: 5O/GNG8-tTA/OMP-tTA/TetO-Toxin. 5O signal via
tauCherry. Olfactory Bulb Dissection. Scale bar: 500 μm. A. 45-day-old male mouse. B. 87-day-old female mouse. C. 205-dayperiglomerular
old male mouse. cell nuclei, visualized using TO-PRO-3 in Figure 39A. Strikingly, though non-5O axons
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Importantly, this effect is detected in the same 29-day-old animal that had a seemingly healthy epithelium
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Fig. 38. 5O projections are present in older TetO-Toxin mice. Genotype: 5O/GNG8-tTA/OMP-tTA/TetO-Toxin. 5O signal via
tauCherry. Olfactory Bulb Dissection. Scale bar: 500 μm. A. 45-day-old male mouse. B. 87-day-old female mouse. C. 205-dayold male mouse.

TetO transgene repression by HR constructs. Thus is appears as though activating the transcriptional
potential of HR constructs is adequate to limit TetO activity, regardless of whether or not TetO is already
transcriptionally active. The exception to this conclusion is in the context of GNG8-tTA and TetO-ORs,
which is presented in Chapter 3.

Fig. 39. The dorsal portion of the bulb of a TetO-Toxin animal is devoid of non-5O projections. Genotype: 5O/GNG8tTA/OMP-tTA/TetO-Toxin. 5O signal via tauCherry. Golf signal via Anti-Golf+AF488 antibodies. Nuclear signal via TO-PRO-3.
Scale bar: 100 μm. A vs B. Same animal, A comes from a more anterior section of the Olfactory bulb compared to B.

2.4 An HR transgene lacking an OR coding sequence can interfere with TetOM71 expression
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Fig. 39. The dorsal portion of the bulb of a TetO-Toxin animal is devoid of non-5O projections. Genotype: 5O/GNG8tTA/OMP-tTA/TetO-Toxin. 5O signal via tauCherry. Golf signal via Anti-Golf+AF488 antibodies. Nuclear signal via TO-PRO-3.
Scale bar: 100 μm. A vs B. Same animal, A comes from a more anterior section of the Olfactory bulb compared to B.

5V (5x21 Venus) is an HR construct that does not code for an OR and thus likely acts as a “Null
OR” gene leading to the expression of another OR locus that can produce OR protein. 5V is broadly
expressed in the epithelium and olfactory bulbs, marking much of the glomeruli on the dorsal bulb surface
(Fig. 40A). As noted previously, TetO-M71 expression via CAM-tTA will also mark much of the bulb
surface (Fig. 26B). The glomerular projections of the two transgenic systems massively overlap. If HR
transgenes require an OR coding sequence to suppress TetO transgenes, then it would not be
unexpected for 5V and TetO-M71 to colabel the same glomeruli.

Fig. 40. 5V glomerular projections do not change in the context of CAM-tTA/TetO-M71 activity. A. Genotype: 5V. 5V
signal via Venus. Olfactory Bulb Dissection. 41-day-old female mouse. Scale bar: 500 μm. B. Genotype: 5V/CAM-tTA/TetOM71. 5V signal via Venus. Olfactory Bulb Dissection. 41-day-old male mouse. Scale bar: 500 μm.

The combination of 5V, CAM-tTA, and TetO-M71 produces animals with 5V projections that do
not differ from control 5V animals (Fig. 40B), in line with the previous results wherein TetO-M71 failed to

Fig. 40. 5V glomerular projections do not change in the context of CAM-tTA/TetO-M71 activity. A. Genotype: 5V. 5V
signal via Venus. Olfactory Bulb Dissection. 41-day-old female mouse. Scale bar: 500 μm. B. Genotype: 5V/CAM-tTA/TetOeliminate
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distribution (Fig. 41A). The brighter, medial bundles of 5V projections are within the Class I domain and
thus 5V is likely expressed in Class I OSNs alongside a Class I OR (Section 1.9); similarly, 5V should be
Fig. 40. 5V glomerular projections do not change in the context of CAM-tTA/TetO-M71 activity. A. Genotype: 5V. 5V
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The 5V signal in the Class I bundle is on average two-fold brighter than 5V signal in the surrounding
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Fig. 40. 5V glomerular projections do not change in the context of CAM-tTA/TetO-M71 activity. A. Genotype: 5V. 5V
signal via Venus. Olfactory Bulb Dissection. 41-day-old female mouse. Scale bar: 500 μm. B. Genotype: 5V/CAM-tTA/TetOM71. 5V signal via Venus. Olfactory Bulb Dissection. 41-day-old male mouse. Scale bar: 500 μm.

Class II domain (N=3) and this is still the case for 5V glomeruli in the CAM-tTA/TetO-M71 background
(Fig. 41B). The TetO-M71 signal in the Class II domain appears weak, but does overlap with the 5V
signal. Critically, within the Class I domain TetO-M71 signal appears further reduced, and is significantly
lower in Class I glomeruli compared to Class II glomeruli (Fig. 41C).

Fig. 41. The non-OR-coding HR construct 5V can suppress TetO-M71 expression. HR constructs do not need to express
OR protein to suppress TetO-M71 expression in Class I OSNs. A. Genotype: 5V/CAM-tTA/TetO-M71. 5V signal via Venus.
TetO-M71 signal via Anti-βgal+AF647 antibodies. Olfactory Bulb Dissection. 38-day-old male mouse. Scale bar: 500 μm. B.
Scatterplot showing 5V signal via Venus in presumed Class I and Class II glomeruli obtained from pooling three groups of
measurements from two 5V/CAM-tTA/TetO-M71 animals. An unpaired t-test was significant. Black lines are the means. C.
Scatterplot showing TetO-M71 signal via Anti-βgal antibody in presumed Class I and Class II glomeruli obtained from pooling 3
groups of measurements from 2 5V/CAM-tTA/TetO-M71 animals. An unpaired t-test was significant. Black lines are the means.
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Fig. 41. The non-OR-coding HR construct 5V can suppress TetO-M71 expression. HR constructs do not need to express
OR protein to suppress TetO-M71 expression in Class I OSNs. A. Genotype: 5V/CAM-tTA/TetO-M71. 5V signal via Venus.
TetO-M71 signal via Anti-βgal+AF647 antibodies. Olfactory Bulb Dissection. 38-day-old male mouse. Scale bar: 500 μm. B.
Scatterplot showing 5V signal via Venus in presumed Class I and Class II glomeruli obtained from pooling three groups of
measurements from two 5V/CAM-tTA/TetO-M71 animals. An unpaired t-test was significant. Black lines are the means. C.
Scatterplot showing TetO-M71 signal via Anti-βgal antibody in presumed Class I and Class II glomeruli obtained from pooling 3
groups of measurements from 2 5V/CAM-tTA/TetO-M71 animals. An unpaired t-test was significant. Black lines are the means.

Several speculative conclusions can be drawn from this result. HR constructs don’t need to
express an OR and induce a feedback mechanism to suppress TetO expression. More specifically, 5V
can suppress TetO-M71 expression in Class I OSNs; importantly, TetO-M71 signal is otherwise present in
the Class I domain without 5V (Fig. 26B). Sections through the bulb and epithelium with antibodies
against Beta-galactosidase and Class I or Class II OSNs can further test this claim. It is not clear if 5V
and TetO-M71 coexpress extensively in Class II OSNs, but it is possible that the apparent glomerular
colabeling in the Class II domain does not translate into OSN coexpression; neither 5V nor TetO-M71 are
ubiquitously expressed in OSNs. That said, the poor TetO-M71 signal in Class II OSNs might be due to
5V-mediated suppression of TetO-M71 expression if they are active in the same OSNs. The differential
results in the Class I and Class II domains require further investigation via bulb and epithelial sections.
The 5V transgene should be limited in its ability to influence TetO transgenes via translational and
post-translational mechanisms due to expressing a fluorescent marker protein rather than an OR. Overall,
I believe it is more likely that HR constructs mediate their initial repression of TetO transgenes at the
nuclear level and HR transgenes reinforce this effect if they express an OR protein. Importantly, this 5Vlinked competition does not appear to be detrimental to the formation of glomeruli and presumptive the
expression of endogenous OR genes, at least as far as the Class I repertoire is concerned. In the similar
context of 5V and an HR-OR transgene, result produced by other Feinstein lab members is in line with
the data in this segment: the two constructs are nearly mutually exclusive in the olfactory bulbs. This
further suggests a common medium of interaction between HR and TetO transgenes.
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Chapter 3: Results Part 2
Early TetO-OR Expression Capitalizes on a Broad Window of Competence
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Gene activation requires that transcription factors associate with their target genes, but the
process might have numerous barriers in the way of success: not enough transcription factor protein,
false or competitive binding sites, silenced binding sites and inhibitors are some examples that come to
mind. Yet given enough time or the right moment in time, it is likely that at least one transcription factor
will bind a specific gene promoter. Some of my more unusual results with the 5O and TetO transgenes
are in the context of aging and timing.

3.1 5x21 OR1A1 marks additional glomeruli in a time-dependent manner
The High Representation (HR) constructs used in this thesis are transgenes that likely require the
presence of the LHX2 transcription factor to function, which is broadly expressed in the mature OSN
layer, albeit at lower levels compared to the more basal portion of the epithelium 143. The continuous
presence of LHX2 might allow endogenous OR genes to activate after OSN maturation, but this potential
could be negligible due to the singularity-associated feedback. HR constructs might overcome these
negligible activation kinetics due to their promoter/enhancer structure and locus of integration. A series of
observations I made with regard to the 5O bulbar signal and animal age led me to believe that the 5O
transgene can overcome this singularity-associated feedback and activate after OSN maturation.
5O is represented in a large population of OSNs and generates numerous interconnected
glomeruli in the Dorsal Class I and Class II domains (Fig. 27A,B; Fig. 42A). These tight beads of glomeruli
are formed from fairly thin axon bundles, and though variability exists between animals and even between
bulbs in the same animal, the relationship between the 5O transgene and its projection pattern is
reasonably consistent. Generally, the anterior/lateral portion of the olfactory bulbs in an animal with the
5O transgene contains tight 5O axon bundles and no 5O glomeruli, but this is not the case in older
animals (Fig. 42A vs. 42B). Older animals have a propensity to present broad sheets of 5O axons on the
bulb surface and numerous glomeruli visible below these sheets. In a crude attempt to quantify this ageassociated development, a ratio of the average tauCherry signal in this anterior region relative to the
average signal intensity in all 5O-positive bulbar structures was calculated. The anterior tauCherry signal
in 5O mice does appear to increase in an age-dependent manner (Fig. 42E). Surprisingly, this
phenomenon holds true when combining the 5O/non-TetO-Toxin genotypes discussed in this thesis thus
far (Fig. 42F).
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What does it mean that the amount of 5O signal increases with age? Artificially adjusting the
brightness and contrast of a young 5O animal exposes faint 5O signal in additional glomeruli and
between the axon bundles (Fig. 42C,D). The diameter of a single OSN axon is approximately 0.3μm and
a single axon is not easily detectable at low magnification imaging215. Thus either the low intensity 5O
signal represents low tauCherry protein per axon, or this signal is due to only a few axons expressing 5O;
these two possibilities are not mutually exclusive. The expression of the 5O transgene generates
numerous brightly marked, and likely homogeneous glomeruli, which corresponds with the expectations
of singular OR expression, yet the low-level 5O signal is inconsistent with the singularity mechanism.

Fig. 42. 5O glomerular presence increases with age. A-D. Genotype: 5O. 5O signal via tauCherry. Olfactory Bulb Dissection.
Scale bar: 500µm. A vs B. 5O projections in a young mouse versus an older mouse. A. 32-day-old female mouse. B. 155-dayold female mouse. C vs D. An oversaturated image reveals the presence of low-intensity 5O signal, which likely develops into a
more easily detectable signal. 36-day-old male mouse. E. Scatterplot showing the ratio of Anterior 5O signal to total 5O signal at
various ages in 5O animals. The slope is significantly non-zero. F. Similar to E, scatterplot showing the ratio of Anterior 5O
signal to total 5O signal at various ages in 5O-containing animals. The slope is significantly non-zero. This sample pool is
composed of various genotypes, which include those from E, but exclude TetO-Toxin-expressing animals and those with TetOORs under GNG8-tTA control.

Fig. 42. 5O glomerular presence increases with age. A-D. Genotype: 5O. 5O signal via tauCherry. Olfactory Bulb Dissection.
Scale bar: 500µm. A vs B. 5O projections in a young mouse versus an older mouse. A. 32-day-old female mouse. B. 155-day- 50
old female mouse. C vs D. An oversaturated image reveals the presence of low-intensity 5O signal, which likely develops into a
more easily detectable signal. 36-day-old male mouse. E. Scatterplot showing the ratio of Anterior 5O signal to total 5O signal at
various ages in 5O animals. The slope is significantly non-zero. F. Similar to E, scatterplot showing the ratio of Anterior 5O
signal to total 5O signal at various ages in 5O-containing animals. The slope is significantly non-zero. This sample pool is
composed of various genotypes, which include those from E, but exclude TetO-Toxin-expressing animals and those with TetOORs under GNG8-tTA control.

While alternatives are possible, I believe that the age-dependent increase in 5O signal is a
consequence of 5O transgene activation after the OSN has expressed an endogenous OR. The 5O
transgene can undergo the endogenous singularity mechanism, but might also activate from a quiescent
chromatin state within the lifetime of a mature OSN. As the average age of OSNs increases and reaches
a maximum in older animals, the likelihood of 5O activation will also increase, thus painting the olfactory
bulbs in tauCherry. In the process, endogenous OR genes might be suppressed, though this suggestion
requires further investigation.
In Section 2.3, I brought forth the possibility that OMP-tTA and/or CAM-tTA activate and drive
TetO expression after an endogenous OR gene has activated and after OSN maturation is triggered. If
this is the case, they might be acting in a similar manner to HR constructs. This possibility is supported by
work published in Fleischmann, et al (2013)205, which revealed that a TetO-containing gene can increase
its OSN representation as mouse age increases. Crossing HR and tTA/TetO transgenes strongly
suggested that HRs might disrupt tTA/TetO via nuclear interactions and perhaps tTA/TetO acts through a
similar mechanism when competing against endogenous OR genes to achieve singularity.

3.2 Earlier activation improves the representation of TetO-P2, but not TetO-M71
An immature OSN presents a nuclear environment amenable for de novo endogenous OR gene
activation and OSN maturation; the mature OSN nucleus is not so hospitable and OR gene expression
remains singular. The general concept is not novel: cells lose the potential to activate new genes and
gene programs as they develop. As such, if CAM-tTA and OMP-tTA activate in the environment of the
mature OSN, the associated TetO transgene might experience some resistance in route to activation.
This is not always the case as the TetO-M71 transgene used in this thesis produces the highest OSN
representation out of ten TetO-M71 mouse founder lines each crossed to OMP-tTA204. TetO-M71
provides an interesting contrast to the low representation TetO-P2 transgene in the context of tTA activity
in immature OSNs.
The TetO-M71 transgene in combination with CAM-tTA is densely represented in olfactory
epithelium, yet the TetO-P2 transgene is sparsely located across the olfactory turbinates (Fig. 26A vs Fig.
43A). The reduced OSN representation of TetO-P2 compared to TetO-M71 helps account for the
diminished bulbar signal (Fig. 26B vs. Fig. 43B). Since the CAM-tTA driver is not the causative agent in
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this reduced signal, it’s likely that TetO-P2 has poor activation kinetics due to its genomic location or
transgenic composition.

Fig. 43. GNG8-tTA improves TetO-P2 representation, but appears detrimental to TetO-M71 projections. A,B. Genotype:
CAM-tTA/TetO-P2. TetO-P2 signal via GFP. Scale bar: 500 μm. A. Olfactory Turbinate Dissection. 38-day-old male mouse. B.
Olfactory Bulb Dissection. 50-day-old female mouse. C,D. Genotype: GNG8-tTA/TetO-P2. TetO-P2 signal via GFP. Scale bar:
500 μm. C. Olfactory Turbinate Dissection. 29-day-old female mouse. D. Olfactory Bulb Dissection. (Different) 29-day-old
female mouse.
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CAM-tTA/TetO-P2. TetO-P2 signal via GFP. Scale bar: 500 μm. A. Olfactory Turbinate Dissection. 38-day-old male mouse. B.
Olfactory Bulb Dissection. 50-day-old female mouse. C,D. Genotype: GNG8-tTA/TetO-P2. TetO-P2 signal via GFP. Scale bar:
500 μm. C. Olfactory Turbinate Dissection. 29-day-old female mouse. D. Olfactory Bulb Dissection. (Different) 29-day-old
female mouse.

Fig. 43. GNG8-tTA improves TetO-P2 representation, but appears detrimental to TetO-M71 projections. A,B. Genotype:
CAM-tTA/TetO-P2. TetO-P2 signal via GFP. Scale bar: 500 μm. A. Olfactory Turbinate Dissection. 38-day-old male mouse. B.
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Work by Nguyen, et al (2010)211 using GNG8-tTA, which is activated in immature OSNs before
OMP-tTA or CAM-tTA, suggest that this early activation increases the amount of TetO-OR signal in the
olfactory bulbs. In my own work, swapping to GNG8-tTA from CAM-tTA does seem to increase TetO-P2
representation and glomerular presence (Fig. 43C,D), but this confirmation of the time-dependent effect
of TetO activation comes with a startling question. How is the TetO-P2 transgene expressed in
presumably mature OSNs when GNG8-tTA is not active in mature OSNs?
The activity of GNG8-tTA/TetO-tauLacZ is localized to the immature basal region of the
epithelium and not in the more mature apical region, and while Beta-galactosidase signal is located in
axons and dendrites (Fig. 36A), immature OSNs are not known to form glomeruli82. Within the same
publication by Nguyen, et al (2010)211, they see that the mRNA from their TetO-P2 transgene is located in
more apical OSNs that do not express GNG8-tTA mRNA, a striking contrast to GNG8-tTA/TetO-GFP,
both colocalized and restricted to the basal end of the layer. I propose that this phenomenon is likely a
consequence of rapid TetO-OR-mediated OSN maturation alongside dwindling tTA protein that slowly
fails to drive TetO-OR expression. The early expression of TetO-OR takes advantage of the extended
window of maturation potential that exists long before an endogenous OR gene is activated. Interestingly,
taking advantage of an early start with GNG8-tTA and continuity via OMP-tTA allows low-representation
TetO-ORs to massively increase their OSN presence133.
I believe that GNG8-tTA alone driving TetO-OR activity would eventually produce a nonfunctional olfactory system as all OR protein vanishes from the membrane of mature OSNs, possibly
leading to continuous degeneration of these non-functional OSNs. This possibility is not so unlikely as
GNG8-tTA-expressing OSNs tend to have shorter lifespans216 and the olfactory epithelium has a
regenerative limit213. Using GNG8-tTA to drive TetO-M71 expression (Fig. 44) produces OSN
representation features that are similar to GNG8-tTA/TetO-P2 (Fig. 43C), but clearly distinct from the
CAM-tTA/TetO-M71 genotype (Fig. 26A). It is possible that the rather robust activation kinetics of TetOM71 efficiently produces mature OSNs that lose TetO-M71 expression and either remain without Betagalactosidase signal or perish, leaving large gaps on the turbinate surface and misshapen glomerular
projections (Fig. 26A,B vs Fig. 44), supporting a dysfunction phenotype.
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Fig. 44. GNG8-tTA generates defective TetO-M71 expression and projections. A,B. Same animal. Genotype: GNG8tTA/TetO-M71. TetO-M71 signal via X-gal staining. Olfactory Turbinate Dissection. Adult mouse.

Collectively, these results suggest that a GNG8-expressing OSN is receptive to the OR-mediated
Fig. 44. GNG8-tTA generates defective TetO-M71 expression and projections. A,B. Same animal. Genotype: GNG8tTA/TetO-M71. TetO-M71 signal via X-gal staining. Olfactory Turbinate Dissection. Adult mouse.
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relatively stable structure as notable amounts of OR mRNA were located in OSNs that lacked tTA mRNA.
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In earlier results segments, I established that TetO transgene signal is reduced in OSNs that
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those results do not completely eliminate the role of OR expression and subsequent OSN maturation in
restricting TetO expression. When HR constructs follow the canonical mechanism of OR expression, they
would be active before OMP-tTA and CAM-tTA. In the context of nuclear competition, if an HR transgene
activates first, it might have advantage over the TetO transgene by hoarding critical machinery, and if the
HR transgene expresses an OR, OSN maturation-dependent effects could exacerbate the impact on
TetO activity. Thus, if HR and TetO transgenes compete for expression and respond similarly to
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maturation, early TetO-OR activation via GNG8-tTA will disrupt 5O OSN projections by preemptively
triggering OR-mediated maturation and pushing the OSN development state into a restrictive one.

Fig. 45. 5O projections are restricted from the dorsal bulb surface in GNG8-tTA/TetO-M71 animals, but recover with
age. A. Genotype: M71-GFP/GNG8-tTA/TetO-M71. TetO-M71 signal via Anti-βgal+AF647 antibodies. Olfactory Bulb
Dissection. 88-day-old female mouse. Scale bar: 100 µm. B,C. Left and right bulbs. Genotype: 5O/GNG8-tTA/TetO-M71. 5O
signal via tauCherry. Olfactory Bulb Dissection. Scale bar: 500 µm. B. 24-day-old female mouse. C. 110-day-old female mouse.
D. Genotype: 5O/GNG8-tTA/TetO-M71. 5O signal via tauCherry. TetO-M71 signal via Anti-βgal+AF647 antibodies. Olfactory
Bulb Dissection. Adult Mouse. Scale bar: 100 µm.

Due to the differences in the TetO-M71 and TetO-P2 transgenes under the CAM-tTA driver (Fig.
26A,B vs. Fig. 43A,B) and my interpretation of their somewhat similar appearance under the GNG8-tTA
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Fig. 45. 5O projections are restricted from the dorsal bulb surface in GNG8-tTA/TetO-M71 animals, but recover with

impacts on 5O projections. While my results agree with this prediction, the age of the animal, the
representation quality of the TetO-OR transgene, and the post-maturation activation of 5O generate some
striking results.
As noted previously, GNG8-tTA/TetO-M71 will mark plenty of glomeruli, though I predicted the
signal would diminish with age (Fig. 44; Fig. 45A). The 5O transgene produces glomeruli that consistently
cover the dorsal olfactory bulb; under no genetic conditions presented thus far, including TetO-Toxin
expression, has 5O failed to form projections across the dorsal bulb surface (See Fig. 27B; Fig. 42). The
GNG8-tTA/TetO-M71 and 5O bulbar signal profiles appear to overlap, but unlike the CAM-tTA driver, the
dorsal presence of 5O projections is abrogated in the context of GNG8-tTA/TetO-M71 (Fig. 45B).
Remarkably, this outcome is most prominent in younger mice, and the levels of 5O signal appear to
recover in a few months (Fig. 45B vs. 45C). Consistent with my age-associated analysis of the
independent 5O transgene in Section 3.1, 5O signal in the GNG8-tTA/TetO-M71 context recovers in older
animals with dense axon sheets and glomeruli spread throughout the bulb that resemble the TetO-M71
signal in Figure 45A.
My interpretation of this outcome involves several timing steps: 1) GNG8-tTA/TetO-M71 is readily
activated in immature OSNs prior to 5O activation; 2) TetO-M71 matures the OSNs and since the young
epithelium has plenty of new OSNs, much of the epithelium goes through this process; 3) the bulb
becomes predominantly composed of TetO-M71 glomeruli; 4) 5O OSNs that do appear due to nonubiquitous TetO-M71 expression fail to project to their normal positions; 5) the mature OSNs stop
producing tTA from GNG8-tTA and TetO-M71 expression eventually disappears; 6) 5O expression begins
replacing TetO-M71 in the same OSNs and relabeling the associated structures with tauCherry.
Supportively, Figure 45D shows relatively bright 5O signal in the same axons bundles that
contain Beta-galactosidase signal via TetO-M71, which are projecting into glomeruli that are
predominantly Beta-galactosidase-positive. In all age groups presented in this segment, there exist
glomeruli that are faintly marked by tauCherry signal, suggesting that the post-maturation expression of
5O is already in progress. The 5O construct might operate more efficiently in this premature maturation
setting due to lack of endogenous gene activation.
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Fig. 46. Continuous tTA/TetO-M71 expression prevents 5O from recovering its projections. 5O signal via tauCherry.
Olfactory Bulb Dissection. A,B. Left and right bulbs. Genotype: 5O/GNG8-tTA/OMP-tTA/TetO-M71. Scale bar: 500 µm. A. 88day-old male mouse. B. 88-day-old female mouse. C. Genotype: 5O/GNG8-tTA/TetO-M71. 52-day-old female mouse. Scale
bar: 500 µm. D. Right Bulb. Genotype: 5O/OMP-tTA/TetO-M71. 34-day-old male mouse. Scale bar: 500 µm.

Strikingly, the reappearance of the 5O signal is halted in the context of continuous TetO-M71
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M71 expression (Fig. 46). In the 88-day old mice with GNG8-tTA and OMP-tTA, 5O projections either
Fig. 46. Continuous tTA/TetO-M71 expression prevents 5O from recovering its projections. 5O signal via tauCherry.
partially
or completely fail to project to the dorsal bulb surface (Fig. 46A,B), while the 5O signal is already
Olfactory Bulb Dissection. A,B. Left and right bulbs. Genotype: 5O/GNG8-tTA/OMP-tTA/TetO-M71. Scale bar: 500 µm. A. 88day-old male mouse. B. 88-day-old female mouse. C. Genotype: 5O/GNG8-tTA/TetO-M71. 52-day-old female mouse. Scale

robust
in µm.
a 52-day-old
GNG8-tTA
mouse and a 34-day-old
OMP-tTA
mouse
(Fig.
bar: 500
D. Right Bulb.
Genotype: 5O/OMP-tTA/TetO-M71.
34-day-old
male mouse.
Scale
bar: 46C,D).
500 µm. With the

continuous influx of tTA protein, TetO-M71 might continue to be efficiently expressed, reducing the
Fig. 46. Continuous tTA/TetO-M71 expression prevents 5O from recovering its projections. 5O signal via tauCherry.
Olfactory Bulb Dissection. A,B. Left and right bulbs. Genotype: 5O/GNG8-tTA/OMP-tTA/TetO-M71. Scale bar: 500 µm. A. 88activation
of the 5O transgene post-maturation, and keeping the glomerular field inaccessible to nonday-old male mouse. B. 88-day-old female mouse. C. Genotype: 5O/GNG8-tTA/TetO-M71. 52-day-old female mouse. Scale
bar: 500 µm. D. Right Bulb. Genotype: 5O/OMP-tTA/TetO-M71. 34-day-old male mouse. Scale bar: 500 µm.
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Fig. 46. Continuous tTA/TetO-M71 expression prevents 5O from recovering its projections. 5O signal via tauCherry.
Olfactory Bulb Dissection. A,B. Left and right bulbs. Genotype: 5O/GNG8-tTA/OMP-tTA/TetO-M71. Scale bar: 500 µm. A. 88day-old male mouse. B. 88-day-old female mouse. C. Genotype: 5O/GNG8-tTA/TetO-M71. 52-day-old female mouse. Scale
bar: 500 µm. D. Right Bulb. Genotype: 5O/OMP-tTA/TetO-M71. 34-day-old male mouse. Scale bar: 500 µm.

TetO-M71 axons. Perhaps the early and continuously active TetO-OR transgene hordes critical nuclear
machinery that HR transgenes require for activation. This extent of impact on 5O expression was not
observed with other constructs. Thus, under certain conditions, TetO constructs can dominate over HR
constructs.
Under CAM-tTA, TetO-P2 has a much lower OSN representation than TetO-M71, so I proposed
that the rather similar outcomes between TetO-P2 and TetO-M71 under the GNG8-tTA driver represented
different progression in epithelial state. TetO-P2 merely became activated in more OSNs, while TetO-M71
activated and matured OSNs so efficiently that it generated a large population of mature OSNs without
TetO-M71 expression. The GNG8-tTA-driven activation of TetO-M71 blocks 5O projections from making it
to the dorsal bulb surface. The TetO-P2 transgene has less robust activation kinetics than TetO-M71 and
thus I predicted that early TetO-P2 expression would have a different impact on 5O. As such, the
outcome of this cross was a welcome surprise.
In the 5O/GNG8-tTA/TetO-P2 mouse bulbs (Fig. 47A), the 5O projections can be divided into two
major categories: high-level 5O signal without TetO-P2 and low-level 5O signal, some of which does
overlap with TetO-P2. These likely represent 5O activation via the singularity mechanism and via the
post-maturation mechanism, respectively. In the context of GNG8-tTA/TetO-M71 in a young mouse, 5O
projections did not resemble those in control 5O animals (Fig. 45B vs Fig. 42A). With TetO-P2, even
though the 5O bundles are condensed and glomeruli are more converged, 5O projections are present on
the dorsal bulb surface and do not contain as much TetO-P2 signal as the TetO-P2 glomeruli themselves
(Fig. 47B).
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Fig. 47. 5O projections parse out into mutually exclusive and co-expressing structures in the context of GNG8tTA/TetO-P2. A. Top. Left Bulb. Bottom. Right Bulb. Genotype: 5O/GNG8-tTA/TetO-P2. TetO-P2 signal via GFP. 5O signal via
tauCherry. Olfactory Bulb Dissection. 29-day-old female mouse. Scale bar: 500 µm. B. Scatterplot showing TetO-P2 signal via
GFP in 5O and TetO-P2 glomeruli obtained from pooling two groups of measurements from one animal. An unpaired t-test was
significant. Black lines are the means.
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Fig. 47. 5O projections parse out into mutually exclusive and co-expressing structures in the context of GNG8tTA/TetO-P2. A. Top. Left Bulb. Bottom. Right Bulb. Genotype: 5O/GNG8-tTA/TetO-P2. TetO-P2 signal via GFP. 5O signal via
tauCherry. Olfactory Bulb Dissection. 29-day-old female mouse. Scale bar: 500 µm. B. Scatterplot showing TetO-P2 signal via
GFP in 5O and TetO-P2 glomeruli obtained from pooling two groups of measurements from one animal. An unpaired t-test was
significant. Black lines are the means.

I believe this outcome strongly supports the idea that TetO-P2 experiences an increase in
representation that doesn’t take over all OSNs when under the influence of GNG8-tTA, as opposed to the
near-ubiquitous TetO-M71 impact on the development of the olfactory epithelium. Perhaps this is not
unexpected as several of the original TetO-M71 founder mice had limited OSN representation204. The site
of transgene insertion has an impact, positive or negative, on the probability of activation: position-effectvariegation. The reduced TetO-P2 representation allows the 5O transgene to activate in a large quantity
of OSNs that then form homogeneous glomeruli near the expected projection site. The low-level signal
category is more reminiscent of the 5O transgene post-maturation activation with 5O expression taking
over after TetO-P2 matured the OSN and then TetO-P2 deactivated due to lack of tTA protein.
To summarize my interpretations on my timing data: 1) activating earlier, either due to an earlier
driver or increased competitive efficiency due to the promoter or locus, should increase OSN
representation; 2) HR constructs and TetO transgenes can become active outside the usual window of
endogenous OR activation; 3) OR-transgene activation after endogenous-OR-mediated OSN maturation
likely disrupts high-level, singular expression and results in a “takeover” phenomenon that replaces the
endogenous OR gene activity; 4) TetO transgenes activated earlier will disrupt or prevent the activity of
HR transgenes; 5) transiently active TetO transgenes might improve the post-maturation activation
kinetics of HR transgenes by preventing endogenous OR loci from becoming active; and 6) early and
persistent expression of TetO-M71 limits 5O presence in the olfactory bulb. Notably, the post-maturation
activation and subsequent interference with prior OR gene expression is very similar to “Gene Switching”
and the “Post-Selection Refinement” process134,217.
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Chapter 4: Results Part 3
TetO-M71 Glomeruli Parse out HR-M71 OSN Identities
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4.1 M71-GFP axons project into HR-M71 glomeruli in preference to TetO-M71
glomeruli
As described in Section 1.7, OSNs that express the same OR will converge their axons into a
small number of homogeneous glomeruli. Each OR might be linked with certain OSN subtypes, each with
their own properties, and the combination of the OR and OSN subtype gives rise to the axonal “identity”
that promotes homotypic interactions. How do OSNs expressing an endogenous OR interact with OSNs
that express the same OR via an HR promoter/enhancer or the tTA/TetO system? The OR M71 (aka
Olfr151) is well characterized in the literature61,76,131. Gene-targeting the 3’ end of the endogenous M71
gene with an “IRES tauGFP” cassette allows us to marks OSNs that express this OR gene, henceforth
called M71-GFP136. OSNs expressing M71-GFP project their axons into one tight glomerulus on each
dorsal bulb surface (Fig. 48A,B). This axonal property is explored in various HR and tTA/TetO contexts.
The HR constructs that express M71 colocalize with the M71-GFP fibers155, the result of which is
somewhat dispersed M71-GFP axons in the HR-M71 glomeruli (Fig. 49A). The explanation for this
outcome is that HR-M71 axons have the same identity as M71-GFP axons and generate a viable
glomerular site for convergence with M71-GFP axons. This property is not reproduced in the context of
the 5O HR construct, which expresses a different OR from M71-GFP (Fig. 49B). Instead, the 5O impact
on M71-GFP axons lies somewhere in between tight M71-GFP glomerular formation and axon dispersal.
HR constructs contain an M71 Promoter sequence, and are likely biased towards being expressed in an
M71-associated OSN subset. Thus, HR transgenes might interfere with endogenous OR/OSN properties
through two means: 1) reducing the number of OSNs available to express endogenous OR genes, and 2)
introducing copious amounts of OSN axons with the same axon identity into the nerve bundles and the
olfactory bulb.
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Fig. 48. M71-GFP axons converge into dense glomeruli on the dorsal olfactory bulb surface. Genotype: M71-GFP. M71GFP signal via tauGFP. A. Olfactory Bulb Dissection. 99-day-old male mouse. Scale bar: 500 μm. B. Olfactory Bulb Dissection.
Adult female mouse. Scale bar: 100 μm. C. M71-GFP is expressed in OSNs located at the dorsal aspect of the olfactory
epithelium near the cribiform plate. Olfactory Turbinate Dissection. 36-day-old male mouse. Scale bar: 500 μm. Combination of
two images.

Fig. 48. M71-GFP axons converge into dense glomeruli on the dorsal olfactory bulb surface. Genotype: M71-GFP. M71GFP signal via tauGFP. A. Olfactory Bulb Dissection. 99-day-old male mouse. Scale bar: 500 μm. B. Olfactory Bulb Dissection.
Adult female mouse. Scale bar: 100 μm. C. M71-GFP is expressed in OSNs located at the dorsal aspect of the olfactory
epithelium near the cribiform plate. Olfactory Turbinate Dissection. 36-day-old male mouse. Scale bar: 500 μm. Combination of
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Adult female mouse. Scale bar: 100 μm. C. M71-GFP is expressed in OSNs located at the dorsal aspect of the olfactory
epithelium near the cribiform plate. Olfactory Turbinate Dissection. 36-day-old male mouse. Scale bar: 500 μm. Combination of
two images.

Fig. 48. M71-GFP axons converge into dense glomeruli on the dorsal olfactory bulb surface. Genotype: M71-GFP. M71GFP signal via tauGFP. A. Olfactory Bulb Dissection. 99-day-old male mouse. Scale bar: 500 μm. B. Olfactory Bulb Dissection.
Adult female mouse. Scale bar: 100 μm. C. M71-GFP is expressed in OSNs located at the dorsal aspect of the olfactory

Fig. 49. M71-GFP axons present different convergence properties in different HR contexts. M71-GFP signal via tauGFP.
5M and 5O signal via tauCherry. Olfactory Bulb Dissection. A. Genotype: 5M/M71-GFP. 40-day-old male mouse. Scale bar: 500
μm. B: Genotype: 5O/M71-GFP. 110-day-old female mouse. Scale bar: 500 μm.
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Fig. 50. M71 protein generated by TetO-M71 expression is broadly distributed in the olfactory epithelium. A. Genotype:
CAM-tTA/TetO-M71. TetO-M71 signal via Anti-M71+AF647 antibodies. Epithelial Section. 33-day-old female mouse. Scale bar:
100 μm. B. Genotype: 5O/M71-GFP/OMP-tTA/TetO-M71. M71-GFP and TetO-M71 signal via Anti-M71+AF647 antibodies.
Epithelial sections. 34-day-old male mouse. Scale bar: 100 μm. C. Genotype: 4M/OMP-tTA/TetO-M71. 4M signal via tauCherry.
4M and TetO-M71 signal via Anti-M71+AF647 antibodies. Epithelial section. 31-day-old male mouse. Scale bar: 100 μm.
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Fig. 51. M71-GFP axons have reduced self-convergence properties in tTA/TetO-M71 background. M71-GFP signal via
tauGFP. Olfactory Bulb Dissection. A. Genotype: M71-GFP/OMP-tTA/TetO-M71. 38-day-old male mouse. Scale bar: 500 μm. B.
Genotype: M71-GFP/GNG8-tTA/TetO-M71. 88-day-old female mouse. Scale bar: 500 μm. C. Genotype: M71-GFP/GNG8tTA/TetO-M71. 53-day-old male mouse. Scale bar: 100 μm.
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fibers almost exclusively project into HR-M71 glomeruli over non-HR-M71 structures (Fig. 52).
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suggests that tTA/TetO can also use or mimic this mechanism to generate an M71-like identity. It is also
possible that TetO-M71 activation takes over much of the likely small M71-GFP glomeruli, painting them
with βgal protein, though if this was the case, HR-M71 glomeruli would have a mix of M71-GFP and TetOM71 signal, which does not appear to be true. Alternatively, HR-M71 transgenes are preferentially
expressed in the same OSN subtypes that express M71-GFP, but they suppress TetO-M71 expression in
the same population. As such, M71-GFP OSNs are even more similar to HR-M71 OSNs than to TetOM71 OSNs, which then promotes the few remaining M71-GFP axons to converge with HR-M71 axons.

Fig. 52. M71-GFP fibers are found predominantly in 4M glomeruli over TetO-M71 glomeruli. Genotype: 4M/M71GFP/CAM-tTA/TetO-M71. M71-GFP signal via tauGFP. 4M signal tauCherry. TetO-M71 via Anti-βgal+AF647 antibodies.
Olfactory Bulb Dissection. Adult female mouse. Scale bar: 100 μm.

Fig. 52. M71-GFP fibers are found predominantly in 4M glomeruli over TetO-M71 glomeruli. Genotype: 4M/M71GFP/CAM-tTA/TetO-M71. M71-GFP signal via tauGFP. 4M signal tauCherry. TetO-M71 via Anti-βgal+AF647 antibodies.
Olfactory Bulb Dissection. Adult female mouse. Scale bar: 100 μm.

Fig. 52. M71-GFP fibers are found predominantly in 4M glomeruli over TetO-M71 glomeruli. Genotype: 4M/M71GFP/CAM-tTA/TetO-M71. M71-GFP signal via tauGFP. 4M signal tauCherry. TetO-M71 via Anti-βgal+AF647 antibodies.
Olfactory Bulb Dissection. Adult female mouse. Scale bar: 100 μm.
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Fig. 52. M71-GFP fibers are found predominantly in 4M glomeruli over TetO-M71 glomeruli. Genotype: 4M/M71GFP/CAM-tTA/TetO-M71. M71-GFP signal via tauGFP. 4M signal tauCherry. TetO-M71 via Anti-βgal+AF647 antibodies.
Olfactory Bulb Dissection. Adult female mouse. Scale bar: 100 μm.

Fig. 52. M71-GFP fibers are found predominantly in 4M glomeruli over TetO-M71 glomeruli. Genotype: 4M/M71-

4.2 HR-M71 projections segregate in the context of TetO-M71 glomeruli
The context-dependent sorting of M71-GFP axons into HR-M71 and TetO-M71 glomeruli
suggests an overlap in identity. If such an overlap in identity exists, can TetO-M71 influence HR-M71
projections? If the OR protein has a major influence on axon identities, generating olfactory bulbs coated
in the M71 protein could cause some HR-M71 axons to segregate. As an important aside, the increased
number of OSNs expressing an OR via the HR transgenes does not generate one giant glomerulus, but
rather several glomeruli spread across a specific region of the olfactory bulbs (See Fig. 27B). These
multiple glomeruli might represent closely related, but still developmentally segregated OSN
subpopulations. More importantly, a seemingly single HR glomeruli might be composite in nature, formed
from two or more contiguous HR glomeruli (personal observation). Thus, the TetO-M71 glomerular
background might parse out these converged glomeruli.

Fig. 53. 4M glomerular formation produces segregated glomeruli in the context of TetO-M71 expression. 4M signal via
tauCherry. Olfactory Bulb Dissection. Scale Bar: 500 μm A. Example of typical 4M glomerular projections. Genotype: M71GFP/4M. 29-day-old male mouse. B. Example of segregated 4M glomeruli. Genotype: 4M/OMP-tTA/TetO-M71. Adult mouse. C.
A 100% stacked bar graph presenting the shift in 4M glomerular structure. Each Bulb is treated independently. No TetO-M71
Expressed: N=39 Bulbs; TetO-M71 Expressed: N=21 Bulbs. Using an online Fisher Exact Probability Test for the 2x3 Data Set
was significant. D. Number of clearly independent 5M glomeruli without and with TetO-M71 expression. Each Bulb is treated
independently. No TetO-M71 Expressed: N=52 Bulbs; TetO-M71 Expressed: N=14 Bulbs. Unpaired t test was significant with P
= 0.0015. Black lines represent the means.
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Fig. 53. 4M glomerular formation produces segregated glomeruli in the context of TetO-M71 expression. 4M signal via
tauCherry. Olfactory Bulb Dissection. Scale Bar: 500 μm A. Example of typical 4M glomerular projections. Genotype: M71GFP/4M. 29-day-old male mouse. B. Example of segregated 4M glomeruli. Genotype: 4M/OMP-tTA/TetO-M71. Adult mouse. C.
A 100% stacked bar graph presenting the shift in 4M glomerular structure. Each Bulb is treated independently. No TetO-M71
Expressed: N=39 Bulbs; TetO-M71 Expressed: N=21 Bulbs. Using an online Fisher Exact Probability Test for the 2x3 Data Set
was significant. D. Number of clearly independent 5M glomeruli without and with TetO-M71 expression. Each Bulb is treated
independently. No TetO-M71 Expressed: N=52 Bulbs; TetO-M71 Expressed: N=14 Bulbs. Unpaired t test was significant with P

Animals with HR-M71 constructs and TetO-M71 transgenes do not show any dispersal of HRM71 glomeruli as is the case with M71-GFP axons. Yet a subtle impact on the number of segregated or
partially segregated HR-M71 glomeruli is evident. The 4M (4x21 M71 IRES tauCherry) transgene has the
lowest OSN representation of all HR transgenes and generates one large glomerulus on the dorsal bulb
surface alongside several smaller ones (Fig. 53A); notably, the right-facing bulb contains a glomerulus
that looks as though it is formed from several smaller glomeruli. In the context of TetO-M71, the
appearance of these split glomeruli increases and completely segregated glomeruli are also evident,
which produces a significant change in the proportion of possible structural outcomes (Fig. 53B,C). The
5M transgene has increased representation relative to 4M and normally generates several glomeruli, but
in the context of TetO-M71 expression, the average number of 5M glomerular foci per bulb increases
from 4.65 to 6.00 (Fig. 53D).
Thus, HR glomeruli might have converged due to having relatively similar axonal identities
compared to the surrounding glomeruli; the introduction of additional potential sites of convergence
causes HR-M71 projections to segregate into additional glomeruli. Importantly, this interaction between
HR-M71 and TetO-M71 axons might be supported by presence of some TetO-M71 expression in the HR
OSNs themselves, since the suppressive effect of HRs on TetO does not appear to be absolute. An
alternative perspective is that subtle differences in TetO-M71 expression within HR-M71 OSNs generate
differential axon identities, which then promotes the segregation of HR-M71 axons.
Exploring the above possibilities further, the TetO-M71 signal is located in some of the 4M
glomeruli (Figure 54A, circled), though the largest 4M glomerulus appears devoid of TetO-M71 signal.
Results from Section 2.1 support reduced TetO-OR signal in HR-OR glomeruli, though this is not always
clear. Sections through 4M glomeruli reveal the presence of TetO-M71 axons, supporting the observation
of colocalized TetO-M71 and 4M signals; notably these images also support the reduced TetO-M71
signal in HR-OR glomeruli (Fig. 54B,C).
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Fig. 54. 4M glomeruli contain TetO-M71 signal, which can help explain the segregation phenomenon. 4M signal via
tauCherry. TetO-M71 signal via Anti-βgal+AF647 antibodies. A. Genotype: M71-GFP/4M/CAM-tTA/TetO-M71. Olfactory Bulb
Dissection. Adult male mouse. Circled are 4M projections that appear to associate with TetO-M71 signal. Scale bar: 500 μm. B.
Genotype: 4M/CAM-tTA/TetO-M71. Bulb Sections. 43-day-old male mouse. Scale bar: 100 μm. C. Genotype: 4M/OMPtTA/TetO-M71. Bulb Sections. 31-day-old male mouse. Scale bar: 100 μm.
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Fig. 54. 4M glomeruli contain TetO-M71 signal, which can help explain the segregation phenomenon. 4M signal via
tauCherry. TetO-M71 signal via Anti-βgal+AF647 antibodies. A. Genotype: M71-GFP/4M/CAM-tTA/TetO-M71. Olfactory Bulb
Dissection. Adult male mouse. Circled are 4M projections that appear to associate with TetO-M71 signal. Scale bar: 500 μm. B.
Genotype: 4M/CAM-tTA/TetO-M71. Bulb Sections. 43-day-old male mouse. Scale bar: 100 μm. C. Genotype: 4M/OMPtTA/TetO-M71. Bulb Sections. 31-day-old male mouse. Scale bar: 100 μm.

The TetO-M71 signal appears within the 4M glomeruli as though the TetO-M71 axons are a core
structure wrapped by 4M axons. Did TetO-M71 axons invade the 4M glomeruli? Did 4M axons invade a
TetO-M71 glomerulus? Did the 4M transgene activate post-maturation to coat the TetO-M71 glomeruli?
Are the TetO-M71 axons passing through the 4M glomeruli? Did the two groups of axons converge into a
single glomerulus due to having similar identities? These are several of the unanswered questions about
these observations. The 5O transgene presents no obvious deviations in the context of TetO-M71 via
CAM-tTA (Fig. 27B vs. C), thus it appears as though the impact of TetO-M71 expression on HRassociated projections is clearest in the context of homotypic identity. That being said, 5O glomeruli are
also not devoid of TetO-OR signal, which raises more questions.
Sections through an animal containing M71-GFP, 5O, CAM-tTA, and TetO-M71 reveal numerous
remarkable phenomena (Figure 55). Single axons are usually difficult to resolve in Whole Mount images,
so the presence of some stray M71-GFP axons entering a TetO-M71-positive glomerulus suggests that
missing M71-GFP glomeruli in the TetO-M71 context might actually be dispersed and difficult to identify.
Sections through the bulb would help identify the presence of lone M71-GFP axons, and sections through
epithelium would be useful to clarify the changes in M71-GFP representation. Careful analysis of signal
colocalization would also clarify if M71-GFP axons experience TetO-M71 post-maturation activation as in
PSR134 or if those M71-GFP OSNs escape this event due to TetO-M71 activation probabilistically failing.
As noted numerous times, HR glomeruli contain less TetO signal than surrounding glomeruli,
though some signal is still evident, and this is certainly the case for 5O in Figure 55 and other contexts.
Yet the presence of a TetO-M71-positive compartment in the 5O glomerulus is unusual. This region is
positive for both transgenes, while the surrounding 5O glomerular space only contains 5O signal. This is
important because similar effects were apparent in the context of 4M, where the relevance of homotypic
interactions was brought to question; it appears as though certain homotypic effects cannot explain all the
interactions between HR and TetO OSNs. The double-positive compartment in the 5O glomerulus is likely
a consequence of different OSN subpopulations differentially expressing TetO-M71. This results in a
combined 5O+TetO-M71 identity that separates out from the purely 5O-positive collection of axons.
Unfortunately, this results produces more questions than answers. Thus, Figure 55 encapsulates the
complexity of gene expression in Olfactory Sensory Neurons and the uncertainty that still remains.
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Fig. 55. 5O glomeruli contain a compartment with TetO-M71 signal. Genotype: 5O/M71-GFP/OMP-tTA/TetO-M71. M71GFP signal via tauGFP. 5O signal via tauCherry. TetO-M71 signal via Anti-βgal+AF647 antibodies. Epithelial section. 34-dayold male mouse. Scale bar: 100 μm.

Fig. 55. 5O glomeruli contain a compartment with TetO-M71 signal. Genotype: 5O/M71-GFP/OMP-tTA/TetO-M71. M71GFP signal via tauGFP. 5O signal via tauCherry. TetO-M71 signal via Anti-βgal+AF647 antibodies. Epithelial section. 34-dayold male mouse. Scale bar: 100 μm.

Fig. 55. 5O glomeruli contain a compartment with TetO-M71 signal. Genotype: 5O/M71-GFP/OMP-tTA/TetO-M71. M71GFP signal via tauGFP. 5O signal via tauCherry. TetO-M71 signal via Anti-βgal+AF647 antibodies. Epithelial section. 34-dayold male mouse. Scale bar: 100 μm.
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Fig. 55. 5O glomeruli contain a compartment with TetO-M71 signal. Genotype: 5O/M71-GFP/OMP-tTA/TetO-M71. M71GFP signal via tauGFP. 5O signal via tauCherry. TetO-M71 signal via Anti-βgal+AF647 antibodies. Epithelial section. 34-dayold male mouse. Scale bar: 100 μm.

Fig. 55. 5O glomeruli contain a compartment with TetO-M71 signal. Genotype: 5O/M71-GFP/OMP-tTA/TetO-M71. M71GFP signal via tauGFP. 5O signal via tauCherry. TetO-M71 signal via Anti-βgal+AF647 antibodies. Epithelial section. 34-day-

Chapter 5: Discussion
An attempt at self-moderation: trying not to solve olfaction
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The singular expression of an odorant receptor (OR) gene is not a simple affair. An OSN is
believed to activate and maintain transcriptional activity of one OR allele to the exclusion of all other OR
alleles over the lifetime of the OSN. OR genes have different coding sequences, promoter structures, and
are found within a variety of loci, making it difficult to conceptualize how an OSN would distinguish
between activating more than one OR allele. A feedback mechanism is part of the singularity models,
both the Lomvardas model and Feinstein model using the OR protein as the trigger for restricting
secondary OR activation. Using my data and review of the literature, I present my contribution to the
mechanism of singularity.

5.1 TetO-OR and HR-OR warp the bulbar identity field
With hundreds or thousands of OR alleles expressed in singularity forming homogeneous
glomeruli, the olfactory bulb is marked by a kaleidoscope of OR-linked glomerular identities. This is not
the case with active TetO-ORs and with the 5O transgene, both of which are expressed in at least
hundreds of thousands of OSNs. This has a two-layered impact on endogenous OR genes, as viewed
through the lens of M71-GFP. The expression region of these transgenes overlaps with the M71-GFP
zone of expression, suggesting that M71-GFP and other endogenous ORs have reduced OSN
representation due to fewer OSNs that can express them. This reduction might occur by inhibiting M71GFP expression before endogenous OR activation, shortly after endogenous OR activation, or long after
the OSN has matured. To support this predictive loss of representation, performing M71-GFP OSN
counts in those genetic backgrounds would be pertinent; differential representation of endogenous ORs in
these conditions can also be determined using OR-specific antibodies.
Whether or not the representation goes down, M71-GFP axons need to navigate an olfactory bulb
heavily coated in one type of OR protein via TetO or HR transgene expression. In the case of the 5O
transgene with a non-M71 identity, its detrimental impact on M71-GFP projections might be due to
overlapping projections sites; HR glomeruli form prenatally (personal observation) and 5O possibly limits
the available real estate for M71-GFP projections, which in combination with reduced M71-GFP
representation, would then lead to M71-GFP axons failing to productively converge into a single
glomerulus (Fig. 49B).

74

In the context of TetO-M71 expression, M71-GFP glomeruli and axons are occasionally
detectable, but it’s likely that the undetectable M71-GFP axons actually converge into TetO-M71
glomeruli78 (Fig. 51). While this result might be due to TetO-M71 PSR134 repainting the M71-GFP
glomeruli, the activation kinetics of TetO-M71 might preclude M71-GFP axons from actually forming a
glomerulus, thus leaving only a probabilistically rare population of independent M71-GFP axons to
navigate the bulb. Though a more consciousness approach to this data set would be required, the result
is not unexpected. Any mechanism of glomerular convergence depends on the singularly expressed OR
to provide the OSN with a path-finding identity, but the distribution of M71-GFP into several TetO-M71
glomeruli suggest that those glomeruli have sufficiently similar identities to facilitate convergence.
The HR-M71 transgenes present a similar phenotype wherein M71-GFP axons will converge into
the HR-M71 glomeruli155 (Fig. 49A). Most surprisingly is the apparent glomerular preference of M71-GFP
axons in animals with active TetO-M71 and HR-M71; the M71-GFP axons were clearly located in the HR
glomeruli and were not readily detectable in TetO-M71 structures (Fig. 52). The direct interpretation is that
HR-M71 axons generate a more compatible M71 identity than TetO-M71 axons. This might be due to
similarities in M71-promoter activation mechanism between HR-M71 and M71-GFP. Additionally, the
activation of TetO-M71 via GNG8-tTA, CAM-tTA, or OMP-tTA likely produces glomeruli with variable M71
protein concentration or even some amount of OR protein co-labeling, which might impact their ability to
generate a preferable site for M71-GFP axon convergence136. Alternatively, my results suggest a
competition between HRs and TetO transgenes, and if HRs are expressed in an OSN subtype that
overlaps with the M71-GFP OSN subtype, that would limit the ability of TetO-M71 to be expressed in
those OSNs and limit its ability to produce a viable M71-GFP convergence point.
During review of my data, I made note of an increase in 4M and 5M glomeruli in the TetO-M71
background (Fig. 53). I believe that the HR-M71 axons can segregate from each other and converge into
TetO-M71 glomeruli; the images that present this phenomenon suggest that HR-M71 axons coat the
TetO-M71 glomerular core (Fig. 54B,C). These additional 4M/5M glomeruli might represent OSN
subtypes that segregate from each other when additional sites for glomerular formation are made viable,
but remain converged when there are no other M71-based glomeruli. The M71-GFP projections in Figure
49A do not appear throughout all 5M glomeruli likely because 5M is expressed in numerous OSN
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subtypes that do not activate M71-GFP, such as the Class I OSNs forming the Class I domain. But there
are also compartments of the 5M glomerulus that appear void of M71-GFP axons, which I use to the
support the idea that HR glomeruli are likely formed from multiple different OSN subtypes expressing the
same OR. These seemingly giant glomeruli might represent a non-intermingled structure of contiguous
glomeruli, which readily segregate if similar enough glomerular identities are present, as in the case of
TetO-M71 expression. In addition, it would be interesting to see if this phenomenon can be reproduced
with other ORs and if HR glomerular number is affected by animal age.
In the context of cAMP-based glomerular formation, my results do not easily support or reject this
model. My data suggests that endogenous OR genes, HR-OR transgenes, and tTA/TetO-ORs all interact
via the same transcription mechanism, which should make them fairly similar in terms of OR protein
production and thus cAMP activity. On the one hand, M71-GFP and HR-M71 axons can associate with
TetO-M71 axons, suggesting comparable OSN properties (Fig. 54,55). Yet the M71-GFP convergence
differential between HR-M71 and TetO-M71 glomeruli suggests that TetO-M71 OSNs are different from
the other two categories (Fig. 52). The nuclear interference of tTA/TetO does not allow for clear answers.

5.2 HR-OR transgenes limit the activity of TetO transgenes
In the literature, the expression of TetO-OR transgenes in the olfactory system produced some
interesting results (Reviewed in Section 1.25). TetO-OR expression appears to generate singular OR
expression, TetO-M71 reduces endogenous OR mRNA levels, and TetO-ORs can be expressed
exclusively from each other. These results all sound similar enough to endogenous OR expression. Thus,
perhaps it is not so unusual that the TetO-OR transgenes respond to HR-OR expression by producing
less signal (Fig. 28-30). The possible explanation for this outcome is that the OR sequence within the
TetO transgene is the target of HR-OR-induced feedback, but this explanation fails in several ways.
First off, switching to TetO-tauLacZ or TetO-tauGFPLacZ produces similar results to TetO-OR,
thus the feedback is either not specific to genes with OR coding sequences, or the interaction between
the two transgene species is more direct (Fig. 33). If the feedback step in singularity causes reduced
TetO signal, endogenous OR genes could be adequate to produce this effect, yet the literature suggests
the opposite: CAM-tTA or OMP-tTA driving TetO-M71 mediates an inhibitory effect on endogenous OR
transcript levels134. It would be interesting to see if TetO-tauLacZ, which has no OR coding sequence to
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trigger a feedback, could also produce this effect on endogenous ORs. If so, I would strongly consider
this as further evidence for OR genes and HR/TetO transgenes directly competing for activity in the
nucleus. The olfactory system of animals that express TetO-M71 is still somewhat functional and the
animals appear healthy218, thus TetO-tauLacZ might produce a similar effect without generating an easily
detectable feeding or breeding phenotype. If the activation of TetO-tauLacZ is not entirely ubiquitous,
additional OSN subtypes could be revealed or produced, leading to additional M71-GFP glomeruli. A
similar effect would be detected with the additional presence of HR-M71, wherein the M71-GFP OSNs
would experience a greater effect than HR-M71 OSNs, leading to the formation of independent M71-GFP
glomeruli instead of composite glomeruli. In the case of TetO-M71, this effect is likely undetectable due to
a combination of lack of M71-GFP axons and a complete recoating of almost all OSN axons with M71.
Alternatively, the reduced or eliminated OR protein in the membrane leads to anosmia, which occurs due
to the direct loss of ORs or indirectly via poor OR-dependent glomerular formation and maintenance.
The OMP-tTA and CAM-tTA driver lines used in publication and in my thesis are likely active
either shortly before or after OR-correlated OSN maturation. As a side note, though I claim CAM-tTA is
likely active when OMP-tTA is active based on the common interactions with HR transgenes, this timing
point still needs to be refined or confirmed. The potential post-maturation TetO activation, at least in the
context of OMP-tTA, occurs after endogenous OR activation, after the feedback was already triggered.
It’s possible that TetO can resist this feedback, and thus I postulate it can resist a similar style of
feedback from HR-OR transgenes, but the TetO signal is significantly lower in HR-OR OSNs regardless.
As such, I propose the HR-OR transgenes and TetO transgenes interact competitively in the OSN
nucleus, wherein the HR transgene keeps TetO transgenes below maximal activity. An important
confirmation of this point of interaction is to obtain strong evidence that tTA levels are not affected in HROR OSNs; if they were affected, that would support the alternative non-specific HR-mediated inhibition.

5.3 HR-mediated reduction of TetO-M71 signal does not require OR-mediated
activity
Work using the 5V transgene is possibly the most striking, but it requires repetition to make sure
the outcome is accurate (Fig. 41). 5V does not express an OR, and thus will not trigger a feedback
mechanism; in theory, it should remain as a passenger in OSNs, allowing the OSN to express an
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appropriate OR gene. As it stands, there is clearly a difference in the 5V signal intensity within the
presumptive Class I and Class II domains. Notably, this feature is evident in Figure 40A with just 5V,
though the levels are not quantified. Class I and Class II OSNs do not have the potential to activate ORs
from a different class99; Class I OSNs express a Class I OR from two large clusters, while Class II OSNs
express a Class II OR from up to sixty different loci. These two OSN populations are different from each,
likely in terms of development, heterochromatin state, actively transcribed genes, etc. Thus it is not
unexpected that 5V would be treated differently in the two populations. It is possible that the limited
number of open OR loci in Class I OSNs allows 5V to be expressed more consistently in the Class I
population. Class II OSNs might have numerous open OR loci, which would diminish the efficacy of 5V
activation, leading to the difference in signal intensity between the two class domains.
In this thesis, my data suggests that Class I 5V glomeruli have less TetO-M71 signal than Class II
5V glomeruli. The Class II domain was co-labeled with 5V and TetO-M71, but the two transgenes might
have mutually exclusive expression at the OSN level; the alternative is that the two are co-expressed with
5V reducing the maximum transcription of the TetO transgene. In the Class I domain, it is clear by
microscopy that the TetO-M71 signal is lacking, where it was otherwise very clearly present in non-5V
settings (Fig. 26B). How is 5V mediating this effect? The only mechanistically relevant elements at play
here are the elements of the 5V promoter, composed of five repeats of a consensus homeodomain
sequence and the M71 promoter. Thus, I suggest that 5V limits the transcriptional success of TetO-M71
by sequestering transcriptional machinery from the TetO transgene. Stated alternatively, maximal TetOM71 activation requires the same machinery that 5V and other HR transgenes require, but HR
transgenes have a higher affinity for that machinery, at least in the case of late TetO activation.
The signal overlap in Class II glomeruli can be clarified by generating sections through the
epithelium and looking for axon signal colocalization; this can be further refined by analyzing signals in
the OSNs of the dorsal olfactory epithelium where Class I and Class II OSNs are located. To further
establish that this effect of HR on TetO does not require that the TetO transgenes contain an OR coding
sequence, it would be worthwhile to use the TetO-tauLacZ transgene with 5V to compare the Class I and
Class II glomerular domains.

78

5.4 A Translational Toxin does not prevent OSN maturation, but will limit non-5O
glomeruli
The expression of TetO-Diphtheria Toxin A (TetO-Toxin) in OSNs via the early tTA driver GNG8
does not prevent OSNs from maturing and expressing AC3 and G olf in cilia (Fig. 36B, Fig. 37). This is in
spite of the fact that GNG8-tTA robustly labels the basal OSNs via TetO-tauLacZ (Fig. 36A). Thus, TetOToxin might suffer from position-effect variegation that limits its activation somewhat. Alternatively, this
level of translational inhibition does not prevent OR-mediated maturation. That said, its continued
expression via OMP-tTA will eventually destroy the epithelium 213, thus an OR-mediated feedback is not
abolishing TetO-Toxin expression. Though I am missing data from the epithelium of older TetO-Toxinexpressing animals, the continued presence of 5O in older animals suggests that 5O OSNs survive this
epithelial purge (Fig. 38). I present this result in support of the 5O transgene keeping TetO-Toxin level
from reaching critical levels by sequestering transcriptional machinery that would allow the Toxin to
accumulate.
To further support the prolonged survival of 5O OSNs over endogenous OR OSNs, I should
obtain sections of olfactory bulbs from much older animals, since they could reveal the near-absence of
non-5O axons. If some non-5O structures remain, that could argue that certain endogenous OR genes
can mimic the HR effect, like MOR28 for example. This specific OR is often suggested as a testing target
in my work due to its similarities to HR transgenes as one of the highest represented OR genes 149.
Some Toxin expression is still likely in 5O OSNs, since HR structures in other settings contain some TetO
signal, but this all the more supports a nuclear competition model over some translation-dependent
mechanism. It is noteworthy that the Toxin expression likely limits its own expression by limiting tTA and
Toxin mRNA translation, which further complicates the interaction. That said, the ultimate destruction of
much of the epithelium and the continued presence of 5O glomeruli supports my idea that the toxic effect
is ameliorated via sequestration of shared transcriptional machinery.

5.5 Transient tTA expression produces “inertial” TetO-OR expression
The expression of a gene without the presence of its activator is an unusual phenomenon, but
this is exactly what was detected using GNG8-tTA and TetO-ORs133,211. My perspective on this result is
that the interaction between tTA and TetO produces a structure that can generate high levels of
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transcription, the expressed OR protein triggers maturation in the immature OSN, which then rapidly
changes its expression profile and morphology such that the cell body moves away from the basal
surface. This mature OSN produces enough OR protein to form homogeneous glomeruli, but then the
TetO transgene experiences transcriptional failure. TetO expression will dissipate as the tTA protein is not
replenished by the inactive GNG8-tTA transgene, which is only active in the basal of cells (Fig. 36A). How
is it possible for TetO-OR signal to be located in mature OSNs? I believe that the high-level transcription
of TetO likely involves the formation of a stable, protein-dense structure that maintains efficient activation
of TetO; the maturation process might reinforce this structure by physically shielding and keeping it from
dissipating in short order.
GNG8-tTA seems to improve TetO-P2 representation relative to the CAM-tTA driver; the TetO-P2
transgene likely suffers from position-effect variegation (Fig. 43). Three possible, non-exclusive
explanations are that GNG8-tTA provides a longer window of time to activate TetO-P2, the GNG8-active
period is when the TetO-P2 locus is open and not in the process of a maturation-induced silencing, or the
TetO-P2 locus doesn’t need to compete with an actively transcribed endogenous OR gene. I believe
something different is occurring in the context of GNG8-tTA and TetO-M71 (Fig. 44). TetO-M71 is
expressed near-ubiquitously in the epithelium with either OMP-tTA or CAM-tTA, thus it either does not
suffer, and possibly benefits from position effects. For example, this one TetO-M71 line out of ten founder
lines204 was inserted next to an enhancer sequence that improved its likelihood of activation. The rather
spotty representation pattern seen when switching to GNG8-tTA is likely due to massive swathes of
OSNs that previously matured via TetO-M71, but lost the transcriptional fidelity of the TetO locus and the
Beta-galactosidase protein vanished. While it is possible that the GNG8-tTA transgene also experiences
position effects with reduced probability of activation or reduced tTA production, the dense layer of TetOtauLacZ signal in the basal epithelium of Figure 36A suggests that GNG8-tTA is not a limiting factor in
TetO-M71 expression. So in TetO-OR-driven maturation, the OSNs might degenerate due to loss of ORmediated signaling, leading to an almost Toxin-like turnover of the epithelium and loss of glomeruli. I
predict that TetO-P2 eventually produces such an outcome, but at a much later point in time. Investigating
mice of various ages via sections of the bulb and epithelium would test this idea. The alternative that
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there is no difference in TetO-P2 and TetO-M71 in the context of GNG8-tTA is not likely due to the
different outcomes produced using the 5O transgene (Fig. 45-47).
The GNG8-tTA/TetO-OR-dependent phenomenon is not evident when TetO-GFP or TetOtauLacZ are used, and I believe it is related to the need for high-level OR expression to allow an
immature OSN to mature. In previous segments, I argued for tTA/TetO associating with factors required
for HR and endogenous-OR activation. Thus, I propose that GNG8-tTA/TetO-tauLacZ sequesters a
necessary element for OR activation. That association can dissipate, providing a functional window of
time for OR activation, which is otherwise suppressed by active TetO expression. This event matures the
OSN and pushes it out of the stage with GNG8-tTA expression, whose shutdown keeps the TetO
transgene from ever recovering its previous level of expression. If there were an efficient mechanism to
keep track of OSN age from post-mitosis to the mature stage, I predict that OSNs expressing GNG8-tTA
with any non-TetO-OR take longer to mature. These two transgenes would act as an additional barrier to
OR gene activation.

5.6 5O bulbar presence increases with age
The efficiency of HR transgene activation is evident by the increased OSN representation relative
to native OR genes155. The mechanisms of singularity require that secondary OR genes are not allowed
to activate, but do those same rules apply to HR transgenes? Though HR-OR transgenes contain an
M71-Promoter and an OR coding sequence, they are not located in OR loci and they contain a
multimerized homeodomain sequence. This DNA element binds the LHX2 protein, which is still present in
mature OSNs146. Thus, I formally claim that HR transgenes can become active after an OSN has
matured; any endogenous OR-mediated-feedback can be overcome by the HR transgene in a similar
fashion to TetO transgene activation via the activity of OMP-tTA. The activation efficiency will likely be
reduced outside the developmental window in immature OSNs, but it might be efficient enough to take
over much of the dorsal bulb.
In young animals, the average age of OSNs is lower than it is in older animals since the
epithelium is still growing, but eventually the epithelium reaches its maximal size and a steady-state is
achieved with an average OSN age of 26 days28. Though in need of confirmation via 5O OSN signal
measurement in the epithelium, I believe that 5O increases its representation with time. Through means
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alone, it is clear that the 5O dorsal bulb in older mice is distinct from that in younger mice (Fig. 42A,B).
Using a rather crude measure of signal growth, I determined the ratio of the average 5O signal in the
anterior portion of the olfactory bulb over the average 5O signal of all 5O-positive regions, which helps
counter differences in background for each image, and obtained an age-dependent increase in 5O signal
within the anterior portion of the epithelium. A more refined measure of this property or analogous
approach such as counting glomeruli should improve the significance.
It would be easier to claim that 5O is being expressed in additional OSN subtypes and forming
glomeruli in new positions, but the consistency with which 5O OSNs project towards the posterior end of
the dorsal bulb in other contexts suggests that this is where the OR1A1 protein directs its host axon,
regardless of OSN subtype. Crossing 5O to GNG8-tTA and TetO-M71 or TetO-P2 provides additional
support for my claim of post-maturation 5O activation. In young GNG8-tTA/TetO-M71 animals, most of
the dorsal bulb real estate is occupied by properly matured OSNs with a TetO-M71 identity; this leaves
little room for 5O projections (Fig 45B). There is a clear time-dependent change in bulbar 5O signal in
GNG8-tTA/TetO-M71 animals (Fig. 45B vs C). I propose this outcome is a consequence of several
phenomena: GNG8-tTA/TetO-M71 rapidly matures much of the OSN population passed the window of
endogenous OR activation, but TetO-M71 has an unstable transcriptional structure due to lack of tTA; the
lack of active endogenous OR loci might improve the activation kinetics of 5O, which upon activation
further disrupts TetO-M71 and takes over as the highly transcribed OR-expressing locus of the nucleus. It
would be of interest to see if endogenous ORs like M71-GFP can also repopulate the olfactory bulb in
time, though perhaps only highly represented OR genes like MOR28 can achieve this phenomenon after
a maturation-mediated silencing event.
The 4M and 5M transgenes were not analyzed in an age-dependent context, though they might
exhibit some signs of post-maturation activation via an increased presence of glomeruli. That said, 4M
and 5M OSN representation is at least five-fold lower than 5O, an indication that the likelihood of
activation is lower due to their insertion site. As such, 4M/5M might not have a high enough activation rate
to accumulate in an OSN population that is going through a constant degeneration/regeneration cycle.
The use of GNG8-tTA driving TetO-OR revealed post-maturation activation with the 5O transgene and

82

repeating the cross with 4M and 5M would test if the phenomenon is specific to 5O or a feature of the
multimerized homeodomain enhancer in HR transgenes.
I claimed that TetO-P2 and TetO-M71 via GNG8-tTA do not produce the same outcome within
the same period of time. The expression of 5O makes that very clear (Fig. 45B vs. Fig. 47). In animals
that differ in age by only five days, 5O projections and glomeruli are present on the dorsal bulb surface in
TetO-P2 animals, but lacking in TetO-M71 animals. I believe that in this case, despite the early start via
GNG8-tTA, TetO-P2 is not activated in all immature OSNs, which allows 5O to maintain a fairly normal
course of development. The 5O projections are more condensed, possibly because TetO-P2 is taking
over some bulbar surface area, similar to TetO-M71, which limits the projections sites for 5O axons. More
strikingly, there are anterior regions of the bulb with weak 5O signal that also present TetO-P2 signal; this
might represent the takeover of TetO-P2 OSNs by post-maturation activation of 5O. A similar property is
detected in the GNG8-tTA/TetO-M71 glomeruli, with weakly marked 5O structures and some unusual colabeled glomeruli (Fig. 45B,D). The activity of GNG8-tTA/TetO-OR likely paves the way for postmaturation 5O activation, perhaps in a similar way that Class I OSNs promote 5V activation by limiting OR
locus competition.
OMP-tTA, CAM-tTA, and GNG8-tTA do not put a permanent damper on the ability of 5O to
populate or repopulate the bulbar field, but this fails in the context of continuous tTA expression starting
from before 5O is activated and afterwards (Fig. 46). GNG8-tTA/TetO-M71 already has an impact on 5O
projections in young animals, so the absence of the heavy repopulation by 5O when OMP-tTA is also
present suggests that TetO-M71 OSNs are no longer available for take over. Thus, TetO activity can
prevent post-maturation 5O activation. Perhaps the barriers to HR activation are too high because the
ideal window of preparation during the immature OSN state was rushed through, the maturation feedback
was triggered, and the necessary machinery is already well established within the grasp of the TetO
locus. HR transgenes never completely overpowered TetO expression, thus it is not unlikely that certain
circumstances can bias the competition in favor of the TetO transgene. My claims in this Section would be
bolstered with several more examples, in general and in the context of aging.
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5.7 A Markov Chain visualization of high-level transcription
Our perspective on the world shifts between probabilistic and deterministic language. At the
nanometer scale, we have a solid understanding of how molecules interact with each other, but we have
difficulty identifying the exact history or calculating the exact future activity for one molecule, such as a
transcription factor. Instead, we move to a larger scale and start depending on probabilistic events and
collective activities: the most profitable or detectable of outcomes, such as the activation of a target gene.
Scaling up to the size of a cell, we have a list of genes that definitively specify subtypes or developmental
time points. Scaling to the collective organism, uncertainty returns and probability is our only recourse, as
in the prediction of human disorders. What is most appropriate, probability or determinism, to discuss
singularity? Perhaps probability and determinism are both necessary to improve our understanding.
In organizing my thoughts, I present a self-produced Markov chain to describe how individual OR
genes might change in some small period of time as they overcome transcriptional barriers (Fig. 56A). A
Markov chain is a stochastic model describing the likelihood that a particular event will occur based on
the current state or circumstance of the subject, but independent of previous states219. In the context of
transcription, each gene has some likelihood of generating an mRNA product in some window of time; a
gene needs to pass through various intermediate states to reach a transcriptionally functional state. For
example, a gene located in constitutive heterochromatin is highly unlikely to lose heterochromatin marks,
become physically accessible, gain pro-activation marks, associate with transcription factors, and recruit
an RNA polymerase in short order. Each change is probabilistic, and even though the likelihood of
becoming transcriptionally active is based on chance, that event can reach functional inevitability.
The chain in Figure 56A defines the status of an OR gene and the likelihood of transitioning
between states. Each circle represents the current state of the OR gene and each arrow points to the
next possible state within some unit of time. The probabilities associated with each arrow are the
likelihood of the OR gene undergoing a particular state change including no change at all. These states
and transitions were not selected for exactness, but are what I believe to be fair descriptors for gene
states. The transition values are not based on any direct data and were selected by me to illustrate a
potential journey of an OR gene and the transcriptional barriers in its way towards high level transcription.
The states are as follows: 1) the locus is silent within heterochromatin and physically inaccessible; 2) the
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locus loses silencing marks; 3) DNA-binding proteins begin to bind to the locus; 4) transcription factor
proteins associate with the locus; 5) low-level basal transcription is achieved; 6) the locus achieves highlevel transcription.

Fig. 56. A Markov Chain describing the probabilistic journey of an OR gene to high level activity and singularity. The
states represented in circles and the state transitions represented with arrows are selected for reasonable accuracy, but the
probability of a state transition associated with each arrow is not based on evidence and were selected for demonstration
purposes. A. OR genes are likely in a silent state prior to the window of time permitting OR gene activation, thus the likelihood
that any one OR gene reaches high level expression is improbable. That said, with enough participating OR genes and enough
time, high level transcription is inevitable. B. As with A, the structure of this Markov chain is unlikely to stand up to scrutiny. The
composition of HR and TetO transgenes promotes their association with DNA-binding proteins, and thus rapidly escalates the
locus into a transcriptionally competent domain. Though certain activation barriers are still present, both sets of transgenes are
highly efficient in comparison with endogenous OR genes. The color associated with each arrow represents the relative
probability of a specific transition compared to Endogenous OR genes in A; Blue/Green: more likely, Red/Orange: less likely.

An OR gene begins its existence at state 1. In a “small moment” of time, that OR gene has some
likelihood (0.01) of transitioning to state 2. Functionally, that OR locus has become slightly more
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Fig. 56. A Markov Chain describing the probabilistic journey of an OR gene to high level activity and singularity. The
states represented in circles and the state transitions represented with arrows are selected for reasonable accuracy, but the
probability of a state transition associated with each arrow is not based on evidence and were selected for demonstration
purposes. A. OR genes are likely in a silent state prior to the window of time permitting OR gene activation, thus the likelihood
that any one OR gene reaches high level expression is improbable. That said, with enough participating OR genes and enough

with activating proteins. Certain stages are unstable and the locus rapidly takes a different form, while
others act as stable states.
With this framework in mind, OR genes do not easily reach high level transcription (state 6),
though this chain was produced to suggest that they can accumulate at state 5 to produce low-level
transcription, as is detected in immature OSNs6,72. I propose that once a locus does reach state 6, which
might be defined by association with specific nuclear machinery or threshold of protein density, the
expression of an OR protein increases the barriers for activation and promotes the movement of other OR
genes into less active states, leading to their silencing or near-silencing. In this sense the OR genes do
not exist in a “Markovian” vacuum and the activation chain for each OR gene is interlinked with all other
OR gene chains.
A “Null” OR locus will fail to trigger the feedback event, which leads to its eventual dissociation
from the high-level transcription machinery and the association of a second locus with this machinery.
The null gene could still remain transcriptionally potent, existing between state 5 and 6, and might obtain
high-level transcription once again.
Despite this being just a means of considering the events of the OR loci in the OSN, if something
like a Markov Chain can describe singularity, its likely to be at least slightly different for every OR gene
and certainly different for HR and TetO transgenes (Fig. 56B). HR loci likely experience reduced
activation barriers, such as being located in more open loci, having better stability in certain states, being
more successful in recruiting factors than endogenous OR genes, or as in the case of 5O, resisting an
OR-induced feedback that would prevent post-maturation activation. TetO runs on its own, nonoverlapping track, possibly having few barriers to activation, but converges with OR genes at the final
stage. It disrupts endogenous OR activity, but fails to achieve high level transcription status in the
combined context of “late” CAM-tTA/OMP-tTA activation and HR transgenes. The reverse appears true if
TetO-OR expression begins early via GNG8-tTA, preventing HR-OR from activating; this suggests that
the order of activation is important in defining the relationship between these transgenes.
I previously suggested that GNG8-tTA driving TetO-tauLacZ might increase the barrier to ORinduced maturation by hogging the machinery required to reach high level OR gene transcription and
mature the OSN; perhaps 5V does something similar. These “null” genes could increase the barriers for
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endogenous OR gene activation, but ultimately will not prevent the OSN from achieving singularity and
maturity. The contradictory nature of “null” transgenes interfering with endogenous OR genes, while also
allowing the endogenous OR gene to mature the OSN suggests that it is not high-level expression that
drives maturation, but the potential for this property and thus maturation might simply require a short-term
burst of activity, which an endogenous OR gene could accomplish when competing with high-affinity loci.

5.8 Interpreting the timing of gene activity
With information from the literature, my data, my interpretation of my data, as well as a healthy
dose of guesswork, I generated graphs that mark the course of gene expression of select genes and
transgenes in OSNs (Fig. 57-59).

Fig. 57. Pertinent events in the progression of immature OSNs to mature OSNs. The transitional period between two
concrete developmental stages can be complex, as in the case of OSN maturation. That said, specific genes and programs are
part of a progressive chain of events that delineate the transition of an OSN from immaturity to a functional member of the
olfactory system. The GNG8 gene and thus the GNG8-tTA transgene are associated with the basally localized immature OSNs,
but both are inactive in the mature OSN. The point of no return in the maturation process, indicated with the dashed line, is
when efficient OR gene expression is achieved, which I believe to be the driver of maturation and not just a parallel event.
Maintaining OSN functionality would then depend on producing a continuous supply of OR protein. Likely a byproduct of
maturation, the CAMKIIα and OMP genes become activated, and thus the associated tTA driver lines activate at this point as
well. GNG8-tTA/TetO-OR and HR-OR activate before endogenous OR genes, preventing their activation; similarly, GNG8tTA/TetO-OR activates before HR-OR transgenes and transiently limits their activation.

From all OSN genes and transgenes directly relevant to this thesis, GNG8 and GNG8-tTA are the
earliest to be activated in immature OSNs with regard to a window of developmental competence. I
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Fig. 57. Pertinent events in the progression of immature OSNs to mature OSNs. The transitional period between two
concrete developmental stages can be complex, as in the case of OSN maturation. That said, specific genes and programs are

activation of OMP, OMP-tTA, CAM, and CAM-tTA likely occurs during the transition point between
immature and mature OSNs, placing their activation point after HR transgenes and endogenous OR
genes. This transition point is also when GNG8 and GNG8-tTA become deactivated. With the timing of
individual gene activity in place, the interaction between genes, transgenes, and the state of the OSN can
be extrapolated.

In the simplest case, GNG8 is expressed in immature OSNs, followed by endogenous OR gene
activation, which then leads to maturation, GNG8 downregulation, and OMP/CAM upregulation (Fig.
58A). HR-OR transgenes follow a similar trajectory, but activate earlier than endogenous OR genes in the
immature OSN state (Fig. 58B); thus HR-OR transgene close the developmental window, introducing a
potent barrier to the transcriptional activation of endogenous OR genes. The reverse case might not be
true and HR-OR transgenes, specifically 5O, can activate post-maturation (Fig. 58A). I believe that 5O
activation in this scenario goes hand-in-hand with the disruption of endogenous OR gene, though that is
yet to be corroborated. If this disruption event is true, it would suggest a competitive aspect to activation,
wherein the cell can only support high level expression of one OR gene, whether it is generated during
the developmental window or some point afterwards.
Based on my proposed maturation trigger, the expression of TetO-OR via GNG8-tTA should
activate this trigger, thus taking advantage of the endogenous mechanism to generate OR singularity
(Fig. 58C). In this scenario, the window closes before HR transgenes are likely to activate, thus HR
transgenes are restricted from achieving their dominant presence on the dorsal bulb surface. In young
animals, this effect is apparent when observing the projections of the 5O transgene, whose OSN axons
fail to cross the dorsal bulb surface in a GNG8-tTA/TetO-M71 background. My interpretation of this
phenomenon is in line with current models of OR singularity: the OR-expressing locus that activates first
and generates high-levels of OR protein will allow the OSN to mature and prevent additional OR gene
activation.
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Fig. 58. The timing of gene activation with specific transgenic combinations. A. Genotype: HR-OR. In the majority of
OSNs, an endogenous OR gene provides the singular OR protein and in most cases, this is the only OR-expressing gene in the
OSN. In some OSNs, at some point during their mature state, an HR transgene might activate as there is nothing explicitly
preventing them from doing so. This activated transgene could lead to the disruption of the endogenous OR gene. B. In
immature OSNs that do activate the HR-OR transgene, the event likely occurs earlier on average than endogenous OR genes,
but follows a similar trajectory to endogenous OR genes with regard to marker gene expression. C. The early expression of
GNG8-tTA driving TetO-OR rapidly matures the OSN as indicated by active OMP/CAM expression, but this event deactivates
the source of tTA. Thus the mature OSN loses OR protein and likely degenerates earlier than normal OSNs. This scenario of
mature OSN with no high-level expression is likely amenable to Post-Maturation Activation of HR-OR transgenes, whose
expression will recoat the bald OSN axons with new OR protein. D. The early activation of TetO-OR limits the activation of HROR to some small population, but allows HR-OR to activate during maturity. Continuous expression of TetO-OR prevents this
even from occurring, allowing the associated TetO-OR to provide the singular source of OR protein.

The issue with GNG8-tTA/TetO-OR is that the preventative effect seems to fail, likely due to
GNG8-tTA deactivation in mature OSNs. In this context, I attribute the recovery of 5O projections to postFig. 58. The timing of gene activation with specific transgenic combinations. A. Genotype: HR-OR. In the majority of
OSNs, an endogenous OR gene provides the singular OR protein and in most cases, this is the only OR-expressing gene in the89
OSN. In some OSNs, at some point during their mature state, an HR transgene might activate as there is nothing explicitly
preventing them from doing so. This activated transgene could lead to the disruption of the endogenous OR gene. B. In
immature OSNs that do activate the HR-OR transgene, the event likely occurs earlier on average than endogenous OR genes,
but follows a similar trajectory to endogenous OR genes with regard to marker gene expression. C. The early expression of
GNG8-tTA driving TetO-OR rapidly matures the OSN as indicated by active OMP/CAM expression, but this event deactivates
the source of tTA. Thus the mature OSN loses OR protein and likely degenerates earlier than normal OSNs. This scenario of
mature OSN with no high-level expression is likely amenable to Post-Maturation Activation of HR-OR transgenes, whose
expression will recoat the bald OSN axons with new OR protein. D. The early activation of TetO-OR limits the activation of HR-

maturation activation of the 5O transgene, promoted in part due to the lack of endogenous OR gene
activation and the loss of the tTA-associated nuclear structure responsible for TetO-OR expression. In
this scenario, the 5O representation in the epithelium will abruptly increase, as compared to a more
gradual accumulation in other genetic backgrounds. Under normal circumstances, the OSN nucleus will
maintain a similar nuclear structure around the endogenous OR, which will limit the free-floating pool of
factors that can help activate 5O, hence the limited activation of 5O after maturation. The relevance of
maintaining the nuclear structure associated with TetO-OR is most prominent in the context of both
GNG8-tTA and OMP-tTA, which promote continuous TetO-OR expression and seem to prevent 5O from
undergoing post-maturation activation or PSR134 and recovering dorsal bulb signal (Fig. 58D).

Fig. 59. The late activation of TetO-OR suggests a limited potential for high-level transcription in OSNs. A. In the
absence of HR-OR activation, CAM-tTA or OMP-tTA driving TetO-OR, which should become expressed after OSN maturation,
appears to suppress endogenous OR gene expression. As with the case of early and continuous TetO-OR expression in Figure
58D, these OSNs probably prevent the post-maturation activation of HR-ORs. B. During the immature OSN state, HR-OR
activation seems to be the antithesis of high-level TetO-OR expression. It is likely that TetO-OR retains some level of activity as
the associated tTA driver should still be active, the TetO transgene fails to produce as much signal in HR-OR OSNs.

The more revealing results are those that involve only the “late” tTA drivers OMP-tTA or CAM-
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the associated tTA driver should still be active, the TetO transgene fails to produce as much signal in HR-OR OSNs.

Fig. 59. The late activation of TetO-OR suggests a limited potential for high-level transcription in OSNs. A. In the
absence of HR-OR activation, CAM-tTA or OMP-tTA driving TetO-OR, which should become expressed after OSN maturation,
appears to suppress endogenous OR gene expression. As with the case of early and continuous TetO-OR expression in Figure

mature gene expression (Fig. 59A). Importantly, since the endogenous OR gene is already activated,
tTA/TetO-OR must therefore interfere with the maintenance of activity rather than the activation process
itself as in the case of PSR134. As such, I propose that OR expression might not be critical to disrupt
endogenous OR expression and the expression of a marker via TetO might produce similar results. This
is a similar to the post-maturation activation of the 5O transgene, whose expression I suggested might
interfere with the activity of the endogenous OR gene.
An important exception to the disruptive nature of CAM-tTA or OMP-tTA driving TetO are the HR
transgenes (Fig. 59B). HR-OR-positive OSNs have lower TetO signal than surrounding OSNs, suggesting
that HR expression limits TetO expression. This effect further supports the notion that an OSN has limited
potential to maintain high-level transcription, the order of activation is important in determining which
locus hordes the transcription machinery, and that HR and TetO activity relies on a shared mechanism.
Collectively, I summarize singularity and maturation as follows: 1) OR gene activation and
maintenance of high-level transcription requires some critical minimum of nuclear protein factors; 2) the
first activated OR-expressing locus capable of high-level transcriptional bursting will initiate OSN
maturation, though a functional OR protein is required to fully mature; 3) the process of maturation
increases the barriers of gene activation for essentially all other OR-expressing loci, generating OR
singularity; 4) some genes can overcome these barriers and activate post-maturation; 5) in the case of
HR and TetO transgenes, post-maturation activation disrupts endogenous OR gene activation as in
PSR134; 6) the order of HR and TetO transgene activation determines which transgene maintains activity
and which transgene is limited; 7) TetO associates with the same limited pool of factors as endogenous
OR genes and HR transgenes to generate high-level expression; 8) the OSN is innately limited to
allowing only one OR-expressing locus (endogenous, HR, TetO) to achieve high level expression.

5.9 Presenting the Olfactory Body
The question still remains: how do I think the OSN generates singularity? I have a complicated
view of the nucleus, as suggested by my attempts to simplify nuclear activity into a Markov chain. I
believe the answer lies in the intersection between OR enhancers, OR gene promoter properties, the
locus, the multimerized DNA elements in TetO and HR, transcriptional bursting220, SuperEnhancers221,222, transcriptional factories223,224 and phase separation225–229. Several of these topics are
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outside my sphere of research and are limited to superficial readings, but I believe they help define OSN
nuclear dynamics. To briefly summarize these ideas: 1) transcriptional bursting describes a “spike-like”
transcription rate resulting from transient association with an efficient transcriptional structure, 2) SuperEnhancers are DNA with dense regions of transcription factor-binding sites that have a sigmoidal
activation response to transcription factor concentration, 3) transcriptional factories are discrete units of
transcriptional machinery that actively transcribe specific loci, and 4) phase separation refers to the
formation of “membrane-less” organelles that have different fluid properties due to the high concentration
of specific proteins. In totality, I believe the OSN nucleus can generate Super-Enhancer activity on OR
enhancers via the accumulation of LHX2 and related proteins into a small region, generating a unique,
phase-separated transcription factory that can maximize the transcriptional burst time of an OR gene; I
call this structure the “Olfaction Body” or “O-body” (Fig. 60). Perhaps to my surprise alone, these ideas for
singularity are not unique to me144, but I did arrive at them independently.

Fig. 60. The Olfaction Body Proposal: A Phase-Separated Super-Enhancer-Like Structure for Generating High Fidelity
Transcriptional Bursting. Though more likely a collection of jargon than an actual explanation, I believe all these ideas are
important in describing the events of normal OSNs and those influenced by my transgenic experiments. The figure uses the
multimerized homeodomain sequence found in HR transgenes, which is functionally similar to the tTA/TetO system.
Endogenous OR genes likely depend on neighboring and distant DNA elements to act like these multimerized promoters.
Importantly, I believe more proteins are involved than those few suggested by my figure. Transcription factors and transcriptionassociated proteins accumulate around a DNA element or structure that contains multiple binding sites. This DNA/protein
structure promotes continued interaction as dissociation is quickly followed by new functional contacts. Eventually, the density
of protein changes the properties within the space, and a nuclear site that can promote copious gene expression and drive OSN
maturation forms: the Olfaction Body.

My addition to the above idea is the following. I provide two interpretations, perhaps only differing
in perspective. HR and TetO transgenes contain multiple copies of a different transcription factor-binding
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site and can generate Super-Enhancer activity without requiring the O-body; their multimerized elements
allow them to efficiently recruit transcription-associated factors. This activity still interferes with the O-body
functionality, as endogenous ORs are likely deactivated in HR-OR and TetO-OR OSNs. In the case of
HRs, the transgene might recruit the O-body wholesale and displace the endogenous OR gene due to
higher overall affinity. Explaining TetO transgenes is less direct, but it’s possible that TetO builds its
transcriptional superiority in OSNs on the back of an O-body-specific element, taking it from the O-body
via better affinity kinetics. In a semantic alternative, HR and TetO generate their own O-body, but the
limited amount of relevant machinery and the Super-Enhancer properties of the two transgene species
leads to the deactivation of endogenous OR genes. When the two transgenes are in the same animal, the
first transgene to activate appears to limit or prevent the expression of the other, which could be
explained as the efficient hording of the secondary factors required for high-level activity.
My best explanation for the transition from immature to mature OSNs is high-level transcriptional
bursting. OR genes are one of the highest expressed genes in the OSN. All models point to an exclusive
transcriptional structure, which would be an efficient means of near-continuous transcription. The
expression of M71-GFP using the promoter of the O/E2 gene failed to achieve singular OR expression79;
while M71-GFP signal and mRNA are detectable in the epithelium, O/E2 is not a highly expressed gene
and this lack of bursting potential could fail in triggering maturation. GNG8 is also not a highly expressed
gene, but through the tTA/TetO system, its promoter can indirectly drive OR expression and OSN
maturation. Lastly, the 5V transgene has higher affinity for the O-body than endogenous ORs, which
should block OR expression, OSN maturation and eliminate glomeruli; this is not the case. As such, an
endogenous OR gene borrows the O-body long enough to produce enough mRNA to trigger maturation.
As an important note, the endogenous OR gene is not always the highest expressed gene in an
OSN, with genes like S100a5, GNG13, GNB1, STOML3, and OMP often presenting higher transcript
levels. The impact that HR and TetO transgenes have on these genes is not clear, but the ability of the
cell to maintain several loci at high transcript levels might be due to minimal overlap in the required
transcription factors associated with each gene; not all bursts are composed of the same proteins nor do
they generate the same quality and quantity of bursts. Perhaps the effects of the TetO-OR transgene is
due to it coincidentally recruiting the same transcription factors as endogenous OR genes. Alternatively, it
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is possible that all high-level genes in the OSN share an O-body, but high-level transcriptional bursting
with rapid O-body turnover keeps transcript levels high. As such, perhaps TetO activity has an impact on
all highly transcribed loci in OSNs and other cells; this point requires further investigation
In summary, the OSN has a limited capacity to produce high-level transcription between the
collective pool of endogenous OR genes, HR transgenes and TetO transgenes as a consequence of the
limited resources in the OSN. The proposed structure that mediates high-level OR expression in the OSN
is the O-body, a protein-dense structure that protects and activates DNA elements that have affinity for it.
HR and TetO transgenes interfere with the O-body, mimicking it or taking its elements due to their more
efficient affinity kinetics virtue of their promoter structures. This phenomenon is likely not unique to OSNs
and any post-mitotic cell with high-level transcription rates likely has its own version of the O-body.
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Chapter 6: Future Directions
There are a lot of paths my research can take, in part because my work was broad and lacked
significant depth in any one genotype. For starters, numerous images need repetition to confirm that the
results are accurate, which can be challenging when a piece of data was collected years ago and the
particular genotype is many months of breeding away. Much of the statistics were done quickly, partly
due to time constraints, but I argue for their validity because I can detect a visual difference in HR and
non-HR structures. In addition, the pooling of similar data actually produced larger overlaps in the data,
but comparisons were still highly statistically significant in most cases. I am not absolving myself of my
responsibility to analyze and present my work at a higher level of quality, but I expect that doing so will
improve my work, not refute my conclusions outright. That said, it would greatly improve my analyses to
get some proper external support to review my statistical approach.
There are several genotype combinations that some of my committee and myself are interested
in. For starters, I had a piece of data that suggested 5V blocked 5O expression in the Class I domain,
which would fall in line with my proposed 5V-mediated block of TetO-M71 expression. That said, I do not
focus on double HR animals. Alternative HR transgenes are available in the lab, so I am interested in
seeing if those transgenes can reproduce the results in my thesis. In this same vein of thought, other
TetO transgenes are available, and more examples of the somewhat mutually exclusive expression of
TetO and HR would reinforce the idea that the OSN has a limited capacity to achieve high-level
transcription.
A critical series of experiments that will immediately analyzed after completing this thesis are
double TetO crosses. If HR and TetO compete for expression, would two TetOs compete? Does it matter
if the two TetOs express an OR? Will a marker protein be adequate to restrict expression levels? The
result might not be as clear due to the fact that the two transgenes would be activated at similar time
points, barring major effect from the locus of integration. These crosses already exist and the animals are
awaiting analysis. In addition, the crosses are generated with either GNG8-tTA or OMP-tTA, allowing
examination of TetO interaction at two different developmental periods of the OSN.
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Additional endogenous loci should be tested in the context of HR and TetO. My data suggests
that M71-GFP is present in those rather debilitating transgenic conditions, but additional OR gene
comparisons would bolster the associated results. To eliminate an M71 bias, it would be appropriate to
analyze the projection patterns of a different endogenous OR gene in the context of HR and TetO
transgenes that express the same OR protein.
Much of my competition conjecture rests on the claim that HR interacts with the TetO transgene
itself, but I lack overwhelmingly definitive evidence that HRs do not interfere with tTA expression, which
could be an alternative explanation for why HR-OR OSNs have reduced TetO signal. This requires
optimizing IHC using a tTA antibody, an endeavor that has failed the few times I tried to repeat it. In the
works are plans to use the RNAscope system to check for tTA mRNA in HR-positive OSNs.
I have additional sets of data that did not pan out as effectively, but perhaps my analysis was
inappropriate. The TetO-DRD2 transgene expresses a non-OR GPCR. It is possible that this receptor can
mimic the properties of ORs in triggering maturation. My first series of transgenic progeny using CAM-tTA
to drive TetO-DRD2 did not generate changes in bulb size, but perhaps using GNG8-tTA in combination
with CAM-tTA would produce an effect. This is similar to how TetO-P2 presentation improved through the
use of GNG8-tTA, though more specifically, publications show that using an “early” and “late” tTA driver
can improve representation211.
Somewhat out of my technical reach, I am interested in finding out if 5V or GNG8-tTA/TetOtauLacZ actually delay the onset of OSN maturation. Such an experiment set would require some form of
lineage tracing and timing, though if the effect is subtle, a more reliable method than the ones used to
identify the timing of OR and OMP expression is required100.
Perhaps the elephant in the room with regard to the use of the tTA/TetO system is the fact that I
made no effort to regulate the activity of tTA via doxycycline administration. While there are currently no
immediate plans to make use of this property, it is still a valuable factor to consider in future experiments.
For example, I made a point that post-maturation activation of 5O is similar to using the OMP-tTA or
CAM-tTA drivers to activate TetO-OR expression, but the timing of activation is not the same. The
tTA/TetO pair are active immediately after the maturation event is triggered, while 5O activity can occur
long after that point. Deactivating tTA until the OSN population is passed the initial wave of neonatal
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maturation could massively abrogate the representation of the associated TetO transgene. In fact, this is
not a novel suggestion and similar work was performed that produces such a result205.
Is there something unique about the interaction between tTA/TetO and the LHX2-dependent OR
genes and transgenes? I should consider alternative means of generating high-level OR expression,
perhaps through the use of the GAL4/UAS system or through transgenic promoters that lead to
overexpression. This would allow me to extrapolate if an O-body element sequestered by tTA/TetO can
be used by other transgenes via a competition with HR-ORs. Similarly, can the tTA/TetO system produce
comparable effects in other post-mitotic cells or is its impact in OSNs a reflection of OSN-specific
properties?
Lastly, and perhaps the most exciting of possible experiments, I am interested in using Single
Cell sequencing to identify the OSN transcriptome in various HR and TetO backgrounds. This would be a
parallel approach to the HR/TetO protein analysis and would also reveal if tTA levels were affected. In
addition, it would be important to determine if OMP-tTA/TetO-M71 completely shuts down endogenous
OR activity, since the currently published data can only suggest this possibility134. In addition, the concept
of limited high-level expression would be addressed by measuring transcript levels of the other highly
transcribed loci: do their levels decline in the HR or TetO backgrounds? The framework for these
experiments is established and I plan to take advantage of the available resources to prepare this data for
publication.
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Chapter 7: Methods
7.1 Animal Care
Mice were bred, stored, and cared for in the CUNY Hunter College Laboratory Animal Facility based on
the Guide for the Care and Use of Laboratory Animals (NHHS Publication No. [NIH] 85-23). Briefly, mice
experience a 12-hour day/night cycle in standard ventilated cages with a minimum 67 square inches of
floor area covered in autoclaved Beta Chip bedding, each cage containing no more than 5 same-sex
adult animals or a single breeding pair plus litter. Litters receive ear tags, are tail clipped for genotyping
purposes, and are removed from breeding cages by 28 days of age. The Hunter College IACUC
approved all mouse experimental protocols used in this thesis.

7.2 Mouse Lines
Animals used in this study involved numerous transgene combinations. All breeding cages were
established to generate heterozygous or hemizygous animals to eliminate the confounding effects of
comparing heterozygous/hemizygous and homozygous properties for each transgene in each
combination, as well as to promote healthier progeny and successful breeding. The High Representation
transgenes are as follows: 5x21 OR1A1 IRES tauCherry; 5x21 M71 IRES tauCherry; 4x21 M71 IRES
tauCherry; 5x21 Venus. The tTA/TetO experiments used several variants for each component. The
following tTA constructs were used: CAMKIIα-tTA (transgene); GNG8-tTA (transgene); OMP IRES tTA
(Gene-targeted Knock-in into 3’ UTR of OMP gene). The following TetO transgenes were used: TetOM71 IRES tauLacZ; TetO-tauLacZ; TetO-Cre; TetO-P2 IRES GFP; TetO-GFPLacZ; TetO-Toxin. A few
ancillary constructs were used: M71 IRES tauGFP (Gene-targeted Knock-in into 3’ UTR of M71 (Olfr151)
gene); ROSA-MTMG (Knock-in into ROSA locus).

7.3 Tail Genotyping
Mouse tails are clipped, placed into 1.5mL Eppendorf tubes, and frozen at -20°C for at least 30
minutes to break cells and release DNA. An abridged tail lysis protocol is used: add 200μL of Viagen
DirectPCR (Tail) lysis reagent (cat#102-T) to each sample and incubate at 85°C in a water bath for at
least 30 minutes. qPCR-based genotyping was performed in duplicate using 1μL tail DNA, 2μL each
primer and 5μL SYBR Green I Master mix (LightCycler 480 cat# 04887352001) per well in a 384-well
plate (TempPlate 1438-4690) using the Roche LightCycler 480 System. Primers were designed using
SerialCloner to produce 50-200 base-pair products and were generated by Eton Bioscience Inc.

7.4 Dissection Protocols: Olfactory Bulbs and Olfactory Turbinates
Animals were prepared to either expose the dorsal surface of the Olfactory Bulbs or the medial surface of
the Olfactory Turbinates. Mice were euthanized using CO2 displacement as per the Hunter College
IACUC regulations. Immediately afterwards, the mouse is dissected to expose the necessary tissue. In
more detail: cut the head away from the body, cut the skin down the middle of the top of the head starting
from the exposed neck, peel the skin off the skull, remove the eyes, and cut off the mandible. A Zeiss
Stemi SV11 Stereomicroscope is used for the rest of the dissection. Use a straight-edged disposable
scalpel to scrape the soft tissue from the top of the exposed skull.
OLFACTORY BULBS: Use the scalpel to carve shallow notches on top of the suture connecting the nasal
bones to the frontal bones and on top of the suture connecting the frontal bones to each other; this will
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weaken the joints and make it easier to remove the bones. The olfactory bulbs are slightly posterior and
deep to the “T” junction formed by the two notches. Use a scalpel to cleave through the sutures
connecting the frontal bones to the parietal bones; cut all the way through the brain and the bone on the
opposite side of the skull. Carefully break through the notch connecting the frontal bones. Use a pair of
forceps to remove the frontal bones by grabbing from the posterior end and forcing breaks through the
remaining notch, minimizing contact with the olfactory bulbs. Use a fine-tipped pair of forceps to remove
the meninges by grabbing it from between the bulbs at the posterior end and pulling it up and over the
bulbs towards the snout.
OLFACTORY TURBINATES: Use the scalpel to carve a shallow notch into the sutures connecting the left
and right sides of the skull from the tip of the nose to the back to the cranium. Align the scalpel point at
the midpoint of the suture connecting the nasal bones to the frontal bones with the blade facing towards
the snout; a midsagittal cut will be performed. With a single motion, plunge the blade straight down
through the skull. With a single motion, keeping the scalpel centered, drag the blade through the nasal
cavity, separating it into two. Similarly, align the blade at approximately the midpoint of the suture
connecting frontal bones to each other and cut towards the posterior. At this step, the skull is still intact.
Use the scalpel edge to carefully carve through the section of skull still connected. Squeeze the tips of a
pair of forceps together and carefully insert them into the fully carved suture and allow the natural
resistance of the forceps to separate the bones. While the two halves of the skull are slightly separated,
use a small pair of scissors to cut through the meninges keeping the olfactory bulbs together. Unfold the
sample and cut through the remaining tissue to separate into two parts; the nasal septum and epithelium
will remain attached to one of the two parts. If the nasal septum and associated epithelium remain intact,
the sample can be further processed as is. If not, remove the epithelium, nasal septum, and cartilage to
expose the olfactory turbinates.
The resulting dissected sample from either procedure can be used for “Confocal Microscopy,” “WholeMount Immunohistochemistry,” “Beta-galactosidase/X-gal Staining,” or “Cryostat Sections.”

7.5 Beta-galactosidase/X-gal Staining
Dissected samples from the “Dissection Protocols” section can be processed for Beta-gal activity in the
Olfactory Bulbs and Olfactory Turbinates. Prepare Buffer A, Buffer B, and the X-gal solutions before the
dissection; store Buffer A and B at room temperature and the X-gal solution in a glass container covered
in foil at -20°C.
1. Fix the freshly dissected sample in a glass container with ice-cold 4% PFA on ice for no more
than 5 minutes.
2. Rinse the sample once with Buffer A at room temperature and discard the solution.
3. Add fresh Buffer A to the sample and incubate at room temperature on a shaker for 10 minutes.
4. Discard Buffer A, add Buffer B, and incubate the sample at room temperature on a shaker for 25
minutes.
5. Make Fresh Buffer C and store it at 37°C until step 4 is complete.
6. Discard Buffer B and use a 60cc syringe with a 0.45μm filter to syringe-filter Buffer C into the
sample container.
7. Leave the sample at room temperature on a shaker for 2-16 hours; longer development time or
higher temperature will increase the X-gal intensity until saturation.
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The sample can be observed by eye or under a dissection microscope (Zeiss Stemi SV11
Stereomicroscope) to determine if longer incubation is required. When the Beta-gal reaction is adequate,
the sample can be used for “X-gal Photography” and later fixed in 4% PFA for long-term storage at 4°C.
Recipes:
X-gal Solution (20 mg/mL): 400 mg in 20 mL of DMF
Buffer A (5L):
Na2HPO4 (add dry)
NaH2PO4 (1M)
MgCl2 (1 M)
EDTA (0.5 M)
Water
pH until 7.4

55g
113mL
5mL
50mL
Add up to 5L

Buffer B (5L):
Na2HPO4 (add dry)
NaH2PO4 (1M)
MgCl2 (1 M)
Na deoxycholate*, 10%
NP4O, 10%
Water
pH until 7.4
*Add AFTER pH
Buffer C (~11 mL):
Buffer B
Ferric CN
Ferrous CN
X-gal Solution

55g
113mL
10mL
5mL
10mL
Add up to 5L

10mL
100μL
100μL
250-500μL

7.6 X-gal Photography
Samples generated from “Beta-galactosidase/X-gal Staining” were photographed using a Canon
EOS 40D camera equipped onto a Zeiss Stemi SV11 Stereomicroscope. The EOS Utility application was
used to remotely image the samples and the Digital Photo Professional application was used to store,
adjust, and export the photographs.

7.7 Whole-Mount Immunohistochemistry
Dissected samples from the “Dissection Protocols” section can be processed for
immunohistochemistry of the Olfactory Bulbs.
1. Fix the sample in 1% Paraformaldehyde (PFA) at 4°C on a shaker overnight.
2. Rinse the sample with fresh 1x Phosphate Buffered Saline (PBS) at least three times to remove
excess PFA.
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3. Block the sample in blocking solution (4% Bovine Serum Albumin, 0.5-2% Triton-X 100, 5%
Normalized Goat Serum, 1x PBS) at 4°C on a shaker overnight.
4. Add the sample to the primary antibody solution (1% Bovine Serum Albumin, 0.5% Triton-X 100,
5% Normalized Goat Serum, 1x PBS, 1:1000 Primary Antibody) and wash at 4°C on a shaker
overnight.
5. Wash the sample with fresh 1x PBS at least three times at 4°C on a shaker for approximately two
hours each time to remove excess primary antibody.
6. Add the sample to the secondary antibody solution (1% Bovine Serum Albumin, 0.5% Triton-X
100, 5% Normalized Goat Serum, 1x PBS, 1:400 Secondary Antibody) and wash at 4°C on a
shaker overnight.
7. Wash the sample with fresh 1x PBS at least three times at 4°C on a shaker for approximately two
hours each time to remove excess secondary antibody.
The sample can now be imaged using “Confocal Microscopy.” The sample can also be processed for
“Cryostat Sections.”

7.8 Cryostat Sections
Samples from “Dissection Protocols” can be processed to produce tissue sections for “Confocal
Microscopy” and “Slide Immunohistochemistry.” Fix the sample in 1% PFA at 4°C overnight. In order to
soften the bone, wash the sample in 0.5M EDTA pH8.0 at 4°C overnight; if the bone remains stiff, wash
the sample at 4°C for an additional 24 hours. In order to protect against freezing damage, incubate the
sample in 10% sucrose in PBS at 4°C for 2 hours; repeat using 20% sucrose in PBS at 4°C for 2 hours;
leave the sample in 30% sucrose in PBS at 4°C overnight. Embed the sample in a foil tube filled with
Tissue Plus Optimal Cutting Temperature (OCT) Compound (cat #4585) and freeze by floating the
sample on plastic dish in liquid nitrogen; store in -80°C. The Leica CM3050 S cryostat was used to
generate sections. Prior to sectioning, transfer the sample to the -20°C cryostat chamber to acclimate and
secure it to a specimen disk using OCT compound. Collect 20μm sections on Superfrost Plus microscope
slides (Fisherbrand cat# 12-550-15) and store them in -20°C. Slides can be used directly for “Confocal
Microscopy” or processed through “Slide Immunohistochemistry.”

7.9 General Immunohistochemistry
The following antibodies were used for “Whole-Mount Immunohistochemistry”: Rabbit anti-Betagalactosidase polyclonal (Cappel/ICN/MP cat#55976) at a dilution of 1:1000-1:2000 and Goat Anti-Rabbit
Alexa Fluor 647 (Invitrogen cat#A-21245) at a dilution of 1:400. The following antibodies were used for
“Slide Immunohistochemistry”: Rabbit anti-Beta-galactosidase polyclonal (Cappel/ICN/MP cat#55976)
1:2000, Guinea Pig anti-M71159 1:200-1:500, Rabbit Anti-VP16 (abcam ab4808) 1:100, Rabbit anti-Gs/olf
polyclonal (Santa Cruz cat # sc-383) 1:100, and Rabbit Anti-AC3 polyclonal (abcam ab199157) 1:100.
Secondary antibodies include Goat Anti-Guinea Pig Alexa Fluor 633 (Invitrogen cat#A21105), Goat AntiRabbit Alexa Fluor 488 (Southern Biotech cat#OB405030), Goat Anti-Rabbit Alexa Fluor 546 (Invitrogen
cat#A11010), and Goat Anti-Rabbit Alexa Fluor 647 (Invitrogen cat#A-21245), all diluted 1:200-1:400.
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7.10 Slide Immunohistochemistry
Tissue slides can be used directly after obtaining sections or from -20°C storage. If obtained from
-20°C, warm up the slides and dry off any liquid.
1. Apply a hydrophobic barrier around the sample using an ImmEdge Pen (Vector Laboratories cat#
H-4000) and rehydrate the sections with 1x PBS.
2. Dry off the slide and add approximately 500μL of blocking buffer to each slide (2% BSA, 5%
NGS, 0.3% Triton-X100, 1xPBS) and incubate at room temperature in a sealed moisture box for
at least 30 minutes.
3. Remove the blocking solution, apply 200μL of the primary antibody solution (1% BSA, 5% NGS,
0.2% Triton-X100, 1xPBS, 1:2000 Primary Antibody), cover the slide with a coverslip, place into a
sealed moisture box, and incubate at 4°C overnight.
4. Carefully remove the coverslip and antibody solution, and wash the slide with 1xPBS in a slide
mailer three time at 4°C on a shaker for 15 minutes each time.
5. Apply 200μL of the secondary antibody solution (1% BSA, 5% NGS, 0.2% Triton-X100, 1xPBS,
1:200 Secondary Antibody), cover the slide with a coverslip, place into a sealed moisture box,
and incubate at 4°C for 1-2 hours.
6. Carefully remove the coverslip and antibody solution, and wash the slide with 1xPBS in a slide
mailer three time at 4°C on a shaker for 15 minutes each time.
Slides can be used in “Confocal Microscopy.” Slides can be temporarily stored in a slide mailer in 1xPBS
at 4°C. For long-term storage, dry the slides as much as possible, apply 2-3 drops of mounting media
(Invitrogen ProLong Gold Antifade Mountant cat# P36930) to each slide, cover the tissue with a coverslip,
let it solidify at room temperature overnight, apply a lacquer (nail polish) to the edge of the coverslip, and
keep at 4°C.

7.11 Confocal Microscopy
Fluorescent images were obtained using a Zeiss Laser Scanning Microscope (LSM) 510
equipped with Argon/2, DPSS 561-10, and HeNe633 laser units. The LSM is equipped with 2.5X (Air), 5X
(Air), 10X(Liquid), and 25X(Liquid) objectives. Whole-mount samples generated directly from “Dissection
Protocols” or “Whole-Mount Immunohistochemistry” are pinned onto a silicone-coated dish and covered
with 1xPBS. Tissue sections from “Cryostat Sections” or “Slide Immunohistochemistry” are kept hydrated
with 1xPBS. Images are generated at 1 Airy Unit with scan settings balanced for speed and quality.

7.12 Image Analysis, Manipulation, Graphs and Figures
The native LSM510 application and the Fiji/ImageJ image analysis application were used to convert
image stacks into projections, add scale bars, modify brightness and contrast, and to make
measurements of average pixel intensity and area. Prism 8 software was used to generate graphs and
perform statistical analyses, which include unpaired t-tests and linear regression. Certain graphs were
generated in Microsoft Excel. Microsoft PowerPoint was used to assemble the figures.
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